Dezheng Huo, Ph.D. - Publications

Affiliations: 
2005 University of Illinois at Chicago, Health Sciences Center, Chicago, IL 60612, United States 
Area:
Public Health

250/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Li JL, McClellan JC, Zhang H, Gao G, Huo D. Multi-tissue transcriptome-wide association studies identified 235 genes for intrinsic subtypes of breast cancer. Journal of the National Cancer Institute. PMID 38400758 DOI: 10.1093/jnci/djae041  0.325
2024 Ochs-Balcom HM, Preus L, Du Z, Elston RC, Teerlink CC, Jia G, Guo X, Cai Q, Long J, Ping J, Li B, Stram DO, Shu XO, Sanderson M, Gao G, ... ... Huo D, et al. Novel breast cancer susceptibility loci under linkage peaks identified in African ancestry consortia. Human Molecular Genetics. PMID 38263910 DOI: 10.1093/hmg/ddae002  0.348
2024 Omoleye OJ, Freeman JQ, Oluwasanu M, Adeniji-Sofoluwe A, Woodard AE, Aribisala BS, Adejumo PO, Ntekim A, Makumbi T, Ndom P, Ajayi IO, Olopade OI, Huo D. Benign breast disease and breast cancer risk in African women: a case-control study. Cancer Causes & Control : Ccc. PMID 38177455 DOI: 10.1007/s10552-023-01837-1  0.367
2024 Zirpoli GR, Pfeiffer RM, Bertrand KA, Huo D, Lunetta KL, Palmer JR. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women. Breast Cancer Research : Bcr. 26: 2. PMID 38167144 DOI: 10.1186/s13058-023-01748-8  0.342
2023 Vannier AGL, Dhungana A, Zhao F, Chen N, Shubeck S, Hahn OM, Nanda R, Jaskowiak NT, Fleming GF, Olopade OI, Pearson AT, Huo D, Howard FM. Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. PMID 38146744 DOI: 10.1002/cncr.35163  0.311
2023 Omoleye OJ, Freeman JQ, Oluwasanu M, Adeniji-Sofoluwe A, Woodard AE, Aribisala BS, Adejumo PO, Ntekim A, Makumbi T, Ndom P, Ajayi IO, Olopade OI, Huo D. Benign breast disease and breast cancer risk in African women: A case-control study. Research Square. PMID 37693385 DOI: 10.21203/rs.3.rs-3301977/v1  0.358
2023 Freeman JQ, Khwaja A, Zhao F, Nanda R, Olopade OI, Huo D. Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. PMID 37676974 DOI: 10.1089/tmj.2023.0225  0.309
2023 Howard FM, Peiffer DS, Huo D. Classification of Breast Cancer According to ERBB2 Immunohistochemistry Scores-Reply. Jama Oncology. PMID 37498624 DOI: 10.1001/jamaoncol.2023.2638  0.348
2023 Freeman JQ, Sheade J, Zhao F, Olopade OI, Nanda R, Huo D. Demographic and Clinical Characteristics Associated With Familiarity, Interest, and Use of Integrative Therapies Among Patients With Breast Cancer. Integrative Cancer Therapies. 22: 15347354231185122. PMID 37462224 DOI: 10.1177/15347354231185122  0.331
2023 Miyashita M, Bell JSK, Wenric S, Karaesmen E, Rhead B, Kase M, Kaneva K, De La Vega FM, Zheng Y, Yoshimatsu TF, Khramtsova G, Liu F, Zhao F, Howard FM, Nanda R, ... ... Huo D, et al. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations. Breast Cancer Research : Bcr. 25: 58. PMID 37231433 DOI: 10.1186/s13058-023-01627-2  0.342
2023 Gao G, Fiorica PN, McClellan J, Barbeira AN, Li JL, Olopade OI, Im HK, Huo D. A joint transcriptome-wide association study across multiple tissues identifies candidate breast cancer susceptibility genes. American Journal of Human Genetics. PMID 37164006 DOI: 10.1016/j.ajhg.2023.04.005  0.341
2023 Freeman JQ, Shubeck S, Howard FM, Chen N, Nanda R, Huo D. Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients. Npj Breast Cancer. 9: 33. PMID 37149628 DOI: 10.1038/s41523-023-00536-z  0.319
2023 Zhao F, Miyashita M, Hattori M, Yoshimatsu T, Howard F, Kaneva K, Jones R, Bell JSK, Fleming GF, Jaskowiak N, Nanda R, Zheng Y, Huo D, Olopade OI. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. Jama Network Open. 6: e233329. PMID 36995716 DOI: 10.1001/jamanetworkopen.2023.3329  0.337
2023 Shubeck S, Zhao F, Howard FM, Olopade OI, Huo D. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US. Jama Network Open. 6: e235834. PMID 36995711 DOI: 10.1001/jamanetworkopen.2023.5834  0.336
2023 Luo J, Kibriya MG, Chen H, Kim K, Ahsan H, Olopade OI, Olopade CS, Aschebrook-Kilfoy B, Huo D. A metabolome-wide case-control study of african american breast cancer patients. Bmc Cancer. 23: 183. PMID 36823587 DOI: 10.1186/s12885-023-10656-1  0.357
2023 Peiffer DS, Zhao F, Chen N, Hahn OM, Nanda R, Olopade OI, Huo D, Howard FM. Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database. Jama Oncology. PMID 36821125 DOI: 10.1001/jamaoncol.2022.7476  0.364
2023 Miyashita M, Balogun OB, Olopade OI, Huo D. The optimization of postoperative radiotherapy in de novo stage IV breast cancer: evidence from real-world data to personalize treatment decisions. Scientific Reports. 13: 2880. PMID 36804591 DOI: 10.1038/s41598-023-29888-z  0.32
2022 Ashi K, Ndom P, Gakwaya A, Makumbi T, Olopade OI, Huo D. Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36215182 DOI: 10.1158/1055-9965.EPI-22-0869  0.364
2022 Han YJ, Zhang J, Hardeman A, Liu M, Karginova O, Romero R, Khramtsova GF, Zheng Y, Huo D, Olopade OI. An Enhancer Variant Associated with Breast Cancer Susceptibility in Black Women Regulates TNFSF10 Expression and Antitumor Immunity in Triple-Negative Breast Cancer. Human Molecular Genetics. PMID 35930348 DOI: 10.1093/hmg/ddac168  0.355
2022 Gao G, Zhao F, Ahearn TU, Lunetta KL, Troester MA, Du Z, Ogundiran TO, Ojengbede O, Blot W, Nathanson KL, Domchek SM, Nemesure B, Hennis A, Ambs S, McClellan J, ... ... Huo D, et al. Polygenic Risk Scores for Prediction of Breast Cancer Risk in Women of African Ancestry: a Cross-Ancestry Approach. Human Molecular Genetics. PMID 35554533 DOI: 10.1093/hmg/ddac102  0.355
2022 Pollock NC, Ramroop JR, Hampel H, Troester MA, Conway K, Hu JJ, Freudenheim JL, Olopade OI, Huo D, Ziv E, Neuhausen SL, Stevens P, McElroy JP, Toland AE. Differences in somatic TP53 mutation type in breast tumors by race and receptor status. Breast Cancer Research and Treatment. PMID 35286522 DOI: 10.1007/s10549-022-06509-3  0.313
2021 Vanderpuye V, Dadzie MA, Huo D, Olopade OI. Assessment of Breast Cancer Management in Sub-Saharan Africa. Jco Global Oncology. 7: 1593-1601. PMID 34843373 DOI: 10.1200/GO.21.00282  0.307
2021 Ansari-Pour N, Zheng Y, Yoshimatsu TF, Sanni A, Ajani M, Reynier JB, Tapinos A, Pitt JJ, Dentro S, Woodard A, Rajagopal PS, Fitzgerald D, Gruber AJ, Odetunde A, Popoola A, ... ... Huo D, et al. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nature Communications. 12: 6946. PMID 34836952 DOI: 10.1038/s41467-021-27079-w  0.324
2021 Adedokun B, Du Z, Gao G, Ahearn TU, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nature Communications. 12: 4198. PMID 34234117 DOI: 10.1038/s41467-021-24327-x  0.37
2021 Han Y, Lv J, Yu C, Guo Y, Bian Z, Hu Y, Yang L, Chen Y, Du H, Zhao F, Wen W, Shu XO, Xiang Y, Gao YT, Zheng W, ... ... Huo D, et al. Development and external validation of a breast cancer absolute risk prediction model in Chinese population. Breast Cancer Research : Bcr. 23: 62. PMID 34051827 DOI: 10.1186/s13058-021-01439-2  0.315
2021 Du Z, Gao G, Adedokun B, Ahearn T, Lunetta KL, Zirpoli G, Troester MA, Ruiz-Narváez EA, Haddad SA, Pal Choudhury P, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, ... ... Huo D, et al. Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry. Journal of the National Cancer Institute. PMID 33769540 DOI: 10.1093/jnci/djab050  0.331
2020 Zhao F, Copley B, Niu Q, Liu F, Johnson JA, Sutton T, Khramtsova G, Sveen E, Yoshimatsu TF, Zheng Y, Ibraheem A, Jaskowiak N, Nanda R, Fleming GF, Olopade OI, ... Huo D, et al. Racial disparities in survival outcomes among breast cancer patients by molecular subtypes. Breast Cancer Research and Treatment. PMID 33111220 DOI: 10.1007/s10549-020-05984-w  0.349
2020 Qian F, Huo D. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-specific Cancers: Cohort Study Analyses from the UK Biobank. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32856611 DOI: 10.1158/1055-9965.Epi-20-0743  0.364
2020 Liu J, Prager-van der Smissen WJC, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, ... ... Huo D, et al. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. 10: 9688. PMID 32546843 DOI: 10.1038/S41598-020-65665-Y  0.499
2020 Ibraheem A, Olopade OI, Huo D. Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base. Cancer. PMID 32521056 DOI: 10.1002/Cncr.32956  0.432
2020 O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Research and Treatment. PMID 32378051 DOI: 10.1007/S10549-020-05603-8  0.449
2020 Huo D, Beaubier N, Jaskowiak N, Nanda R, Fleming G, Hattori M, Rajagopal PS, Ibraheem A, Copley B, Niu Q, Liu F, Sveen E, Yoshimatsu T, Khramtsova G, Zheng Y, et al. Abstract B123: Using eHealth and data science to dissect breast cancer heterogeneity in the Chicago Multi-Ethnic (ChiMEC) Breast Cancer Cohort Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-B123  0.462
2020 Huo D, Kang M, Saulsberry L, Hasan Y. Abstract P4-12-14: Has hypofractionated whole breast radiation therapy become standard of care in the United States? An updated report from national cancer database Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P4-12-14  0.376
2020 Hattori M, Huo D, Beaubier N, Rajagopal PS, Yoshimatsu T, Zheng Y, Sveen E, Khramtsova G, Liu F, Abboushi T, White K, Olopade O. Abstract P4-05-10: Comparative analysis of genomic landscape reveals heterogeneity in HER2-positive primary breast cancers and residual disease following neoadjuvant therapy Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-05-10  0.477
2020 Theiner S, Hu D, Huntsman S, Shieh Y, Fejerman L, Acerbi I, Sawyer SD, Kendall P, Zheng W, Huo D, Olopade OI, Haiman C, Kerlikowske K, Cummings S, John E, et al. Abstract P2-10-05: A breast cancer multi-racial/ethnic polygenic risk score for improved personalized breast cancer screening Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-10-05  0.454
2020 Adedokun B, Du Z, Gao G, Ahearn T, Lunetta KL, Zirpoli G, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Abstract 4613: Cross-ancestry genome-wide association study identifies six new loci for breast cancer in women of African and european ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-4613  0.431
2020 Jia G, Ping J, Yang Y, Sanderson M, Cai Q, Guo X, Blot WJ, Li B, Bandera EV, Bolla MK, García-Closas M, Easton DF, Fadden MK, Gu J, Huo D, et al. Abstract 28: Integrating genomic and transcriptomic data to identify genetic loci associated with breast cancer risk in women of African ancestry Epidemiology. DOI: 10.1158/1538-7445.Am2020-28  0.434
2020 Du Z, Gao G, Adedokun B, Ahearn T, Lunetta KL, Zirpoli G, Troester M, Ruiz-Narváez EA, Haddad S, Figueroa J, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, ... ... Huo D, et al. Abstract 2320: Evaluating a polygenic risk score for breast cancer in women of African ancestry Epidemiology. 80: 2320-2320. DOI: 10.1158/1538-7445.Am2020-2320  0.487
2019 Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Zhou AY, Yoshimatsu TF, Rodriguez A, Madduri RK, Foster IT, Sallam A, Olopade OI, Huo D. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Uganda and Cameroon Women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31871109 DOI: 10.1158/1055-9965.Epi-19-0506  0.467
2019 Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H, Yang L, Chen Y, Zhang X, Wang T, Chen J, Chen Z, Yu C, Huo D, Li L, et al. Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. European Journal of Epidemiology. PMID 31754945 DOI: 10.1007/S10654-019-00585-4  0.467
2019 Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, ... ... Huo D, et al. Two truncating variants in FANCC and breast cancer risk. Scientific Reports. 9: 12524. PMID 31467304 DOI: 10.1038/s41598-019-48804-y  0.373
2019 West AH, Knollman H, Dugan J, Hedeker D, Handorf EA, Nielsen SM, Bealin LC, Goldblatt LG, Willems H, Daly MB, Afghahi A, Olopade OI, Hulick PJ, Shagisultanova E, Huo D, et al. Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study. Cancer Medicine. PMID 31407530 DOI: 10.1002/Cam4.2471  0.406
2019 Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... ... Huo D, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8  0.347
2019 Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Sanni A, Oluwasola O, Ajani M, Fitzgerald D, Odetunde A, Khramtsova G, Hurley I, Popoola A, Falusi A, Ogundiran T, ... ... Huo D, et al. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria. International Journal of Cancer. PMID 31173346 DOI: 10.1002/Ijc.32498  0.414
2019 Friebel TM, Andrulis IL, Balmaña J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, ... ... Huo D, et al. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Human Mutation. PMID 31112363 DOI: 10.1002/Humu.23804  0.361
2019 Kar SP, Brenner H, Giles GG, Huo D, Milne RL, Rennert G, Simard J, Zheng W, Burgess S, Pharoah PDP. Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk. International Journal of Epidemiology. PMID 30929013 DOI: 10.1093/Ije/Dyz047  0.38
2019 Kar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, Dörk T, Evans DGR, Gago-Domínguez M, Giles GG, Hartman M, Huo D, Kaaks R, Li J, Lophatananon A, et al. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. European Journal of Epidemiology. PMID 30737679 DOI: 10.1007/S10654-019-00485-7  0.466
2019 Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, ... ... Huo D, et al. Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 10: 288. PMID 30643118 DOI: 10.1038/S41467-018-07886-4  0.345
2019 Hoffman J, Fejerman L, Hu D, Huntsman S, Li M, John EM, Torres-Mejia G, Kushi L, Ding YC, Weitzel J, Neuhausen SL, Lott P, Echeverry M, Carvajal-Carmona L, ... ... Huo D, et al. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas. Breast Cancer Research : Bcr. 21: 3. PMID 30642363 DOI: 10.1186/S13058-018-1085-9  0.457
2019 Odedina SO, Ajayi IO, Morhason-Bello IO, Babatundetuk A, Huo D, Olopade OI, Ojengbede OA. Influence of a Teaching Session on Breast Self-Examination and Adherence Among Pregnant and Lactating Women in Ibadan, Nigeria Journal of Global Oncology. 5: 9-9. DOI: 10.1200/Jgo.19.18000  0.428
2019 Li S, Huo D, Ojengbede O, Olopade O. Breast Cancer and the Environment: A Pilot Study of Nigerian Women Journal of Global Oncology. 5: 5-5. DOI: 10.1200/Jgo.19.14000  0.448
2019 Abdulkareem FB, Khramtsova G, Adedokun B, Rotimi O, Abudu K, Badmos K, Ibraheem AF, Khramtsov A, Sveen L, Hurley I, Masaya H, Huo D, Olopade OI. Colorectal cancer molecular subtypes by immunohistochemistry in a patient cohort from Nigeria. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E15145  0.348
2019 Hattori M, Rajagopal PS, Sveen L, Khramtsova G, Yoshimatsu T, Beaubier N, Barber M, Abboushi T, Fang L, Zheng Y, White K, Huo D, Olopade OI. Genomic profiling of residual tumor after neoadjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 37: e12106-e12106. DOI: 10.1200/Jco.2019.37.15_Suppl.E12106  0.453
2019 Rajagopal PS, Beaubier N, Hattori M, Sveen L, Khramtsova G, Abboushi T, Barber M, Liu F, Yoshimatsu T, Zheng Y, White K, Huo D, Olopade OI. Determining clinical relevance of genomic heterogeneity in an ethnically diverse cohort of newly diagnosed patients with breast cancer. Journal of Clinical Oncology. 37: 3084-3084. DOI: 10.1200/Jco.2019.37.15_Suppl.3084  0.445
2019 Ibraheem A, Olopade O, Huo D. Abstract P4-08-12: Comparative analyses of the prognostic value of oncotype and mammaprint using the National Cancer Database Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-08-12  0.483
2019 Neerukonda A, Olopade O, Huang E, Huo D. Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-08-05  0.444
2019 Adedokun B, Odedina S, Ojengbede O, Ademola A, Ogundiran T, Huo D, Olopade O, Agwai I, Makumbi T, Ndom P, Gakwaya A. Abstract 624: A case control study of benign breast disease and breast cancer among indigenous African women Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-624  0.454
2019 Ansari-Pour N, Pitt JJ, Dentro S, Fitzgerald D, Zheng Y, Yoshimatsu TF, Rajagopal P, Gruber A, Sanni A, Oluwasola O, Ajani M, Odetunde A, Popoola A, Falusi A, Ogundiran T, ... ... Huo D, et al. Abstract LB-300: The life history of breast cancer in Nigerian women: Evidence for ethnic differences in tumor evolution based on whole-genome sequencing Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-300  0.483
2019 Hattori M, Khramtsova G, Sveen L, Yoshimatsu T, Huo D, Olopade OI. Abstract 4040: PD-L1 expression level and CD8+/FoxP3+T cell ratio in breast cancer and prognosis Cancer Research. 79: 4040-4040. DOI: 10.1158/1538-7445.Am2019-4040  0.382
2018 Titus L, Hatch EE, Drake KM, Parker SE, Hyer M, Palmer JR, Strohsnitter WC, Adam E, Herbst AL, Huo D, Hoover RN, Troisi R. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reproductive Toxicology (Elmsford, N.Y.). 84: 32-38. PMID 30594671 DOI: 10.1016/J.Reprotox.2018.12.008  0.311
2018 Ibraheem AF, Press DJ, Olopade OI, Huo D. Community clinical practice patterns and mortality in patients with intermediate oncotype DX recurrence scores: Who benefits from chemotherapy? Cancer. PMID 30387876 DOI: 10.1002/Cncr.31818  0.342
2018 Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, ... ... Huo D, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 9: 4181. PMID 30327465 DOI: 10.1038/S41467-018-06616-0  0.465
2018 Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Huo D, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132  0.316
2018 Odedina SO, Ajayi IO, Adeniji-Sofoluwe A, Morhason-Bello IO, Huo D, Olopade OI, Ojengbede OA. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria. Bmc Women's Health. 18: 152. PMID 30231883 DOI: 10.1186/S12905-018-0647-4  0.45
2018 Guindalini RS, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova GF, ... ... Huo D, et al. Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30154229 DOI: 10.1158/1078-0432.Ccr-18-0200  0.45
2018 Zheng Y, Walsh T, Gulsuner S, Casadei S, Lee MK, Ogundiran TO, Ademola A, Falusi AG, Adebamowo CA, Oluwasola AO, Adeoye A, Odetunde A, Babalola CP, Ojengbede OA, Odedina S, ... ... Huo D, et al. Inherited Breast Cancer in Nigerian Women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018783977. PMID 30130155 DOI: 10.1200/Jco.2018.78.3977  0.505
2018 Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, ... ... Huo D, et al. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785204. PMID 30113886 DOI: 10.1200/Jco.2018.78.5204  0.346
2018 Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone KE, John EM, Gammon MD, Daly MB, Terry MB, Buys SS, Huo D, Olopade OI, Genkinger JM, Whittemore AS, et al. Germline variation and breast cancer incidence: A gene-based association study and whole-genome prediction of early onset breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29898891 DOI: 10.1158/1055-9965.Epi-17-1185  0.475
2018 Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry. Molecular Carcinogenesis. PMID 29873413 DOI: 10.1002/Mc.22845  0.467
2018 Wang S, Ogundiran TO, Ademola A, Oluwasola OA, Adeoye AO, Sofoluwe A, Morhason-Bello I, Odedina SO, Agwai I, Adebamowo C, Obajimi M, Ojengbede O, Olopade OI, Huo D. Development of a Breast Cancer Risk Prediction Model for Women in Nigeria. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29678902 DOI: 10.1158/1055-9965.Epi-17-1128  0.443
2018 Huo D, Perou CM, Olopade OI. Reported Biologic Differences in Breast Cancer by Race Due to Disparities in Screening-Reply. Jama Oncology. PMID 29543936 DOI: 10.1001/Jamaoncol.2017.5909  0.442
2018 Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson KL, Hennis A, Nemesure B, Ambs S, Olopade OI, Huo D. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry. Breast Cancer Research and Treatment. PMID 29302764 DOI: 10.1007/S10549-017-4638-1  0.415
2018 Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Sallam A, Olopade O, Huo D. Prevalence and Spectrum of Breast Cancer Inherited Mutations in Uganda and Cameroon Women Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.60600  0.479
2018 Odedina SO, Ajayi IO, Morhason-Bello IO, Adeniji-Sofoluwe A, Huo D, Olopade OI, Ojengbede O. Profile of Women With Breast Disorders in Pregnancy and Lactation and Additional Investigation Uptake Journal of Global Oncology. 4. DOI: 10.1200/Jgo.18.10340  0.4
2018 Shang L, Jaskowiak NT, Hedeker D, Olopade OI, Huo D. Pre- and post-treatment body weight and prognosis in a multiethnic cohort of breast cancer patients. Journal of Clinical Oncology. 36: 1501-1501. DOI: 10.1200/Jco.2018.36.15_Suppl.1501  0.43
2018 Whitaker K, Guindalini R, Abe H, Sheeth D, Huo D, Hong S, Churpek J, Verp M, Obeid E, Zheng Y, Amico A, Yoshimatsu T, Olopade O. Abstract P4-02-10: Breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-02-10  0.487
2018 Whitaker K, Abe H, Sheth D, Huo D, Yoshimatsu T, Verp M, Zheng Y, Karczmar G, Guindalini R, Olopade O. Abstract P4-02-01: Recall rates during breast cancer surveillance in high-risk women with dynamic contrast-enhanced magnetic resonance imaging every 6 months: Results from a single institution study Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-02-01  0.402
2018 Wang S, Pitt JJ, Zheng Y, Yoshimatsu TF, Gao G, Riester M, Sanni A, Oluwasola O, Fitzgerald D, Ogundiran T, Babalola C, Popoola A, Falusi A, Winckler W, Obafunwa J, ... ... Huo D, et al. Abstract 287: Germline variants and somatic mutation signatures in breast cancer across populations of African and European ancestry Cancer Research. 78: 287-287. DOI: 10.1158/1538-7445.Am2018-287  0.445
2017 Press DJ, Miller ME, Liederbach E, Yao K, Huo D. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clinical & Experimental Metastasis. PMID 29288366 DOI: 10.1007/S10585-017-9871-9  0.44
2017 Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Huo D. Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29254938 DOI: 10.1158/1055-9965.Epi-17-0755  0.474
2017 Press DJ, Ibraheem A, Dolan ME, Goss KH, Conzen S, Huo D. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Research and Treatment. PMID 29181717 DOI: 10.1007/S10549-017-4587-8  0.373
2017 Troisi R, Hatch EE, Titus L, Strohsnitter W, Gail MH, Huo D, Adam E, Robboy SJ, Hyer M, Hoover RN, Palmer JR. Prenatal diethylstilbestrol exposure and cancer risk in women. Environmental and Molecular Mutagenesis. PMID 29124779 DOI: 10.1002/Em.22155  0.397
2017 Troisi R, Titus L, Hatch EE, Palmer JR, Huo D, Strohsnitter WC, Adam E, Ricker W, Hyer M, Hoover RN. A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk. The Journal of Clinical Endocrinology and Metabolism. PMID 29069384 DOI: 10.1210/Jc.2017-01940  0.312
2017 Gao G, Pierce BL, Olopade OI, Im HK, Huo D. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer. Plos Genetics. 13: e1006727. PMID 28957356 DOI: 10.1371/Journal.Pgen.1006727  0.471
2017 Wang S, Huo D, Kupfer S, Alleyne D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Genetic variation in the Vitamin D related pathway and breast cancer risk in women of African ancestry in the Root Consortium. International Journal of Cancer. PMID 28891071 DOI: 10.1002/Ijc.31038  0.414
2017 Vanderpuye VDNK, Olopade OI, Huo D. Pilot Survey of Breast Cancer Management in Sub-Saharan Africa. Journal of Global Oncology. 3: 194-200. PMID 28717760 DOI: 10.1200/Jgo.2016.004945  0.408
2017 Murphy ME, Liu S, Yao S, Huo D, Liu Q, Dolfi SC, Hirshfield KM, Hong CC, Hu Q, Olshan AF, Ogundiran TO, Adebamowo C, Domchek SM, Nathanson KL, Nemesure B, et al. A functionally significant SNP in TP53 and breast cancer risk in African-American women. Npj Breast Cancer. 3: 5. PMID 28649645 DOI: 10.1038/s41523-017-0007-9  0.377
2017 Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Olopade OI, Zheng Y. Association of breast cancer risk and the mTOR pathway in women of African ancestry in "The Root" Consortium. Carcinogenesis. PMID 28582508 DOI: 10.1093/Carcin/Bgx055  0.494
2017 Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone K, John EM, Gammon MD, Daly M, Terry MB, Buys SS, Huo D, Olopade O, Genkinger JM, Jasmine F, et al. Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Research and Treatment. PMID 28503721 DOI: 10.1007/S10549-017-4287-4  0.459
2017 White MG, Applewhite MK, Kaplan EL, Angelos P, Huo D, Grogan RH. A Tale of Two Cancers: Traveling to Treat Pancreatic and Thyroid Cancer. Journal of the American College of Surgeons. PMID 28473189 DOI: 10.1016/J.Jamcollsurg.2017.02.017  0.324
2017 Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J, Yoshimatsu TF, Pitt JJ, Hoadley KA, Troester M, Ru Y, Lichtenberg T, Sturtz LA, Shelley CS, Benz CC, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. Jama Oncology. PMID 28472234 DOI: 10.1001/Jamaoncol.2017.0595  0.458
2017 Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Huo D, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935  0.433
2017 Feng Y, Rhie SK, Huo D, Ruiz-Narvaez EA, Haddad SA, Ambrosone CB, John EM, Bernstein L, Zheng W, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, et al. Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28377418 DOI: 10.1158/1055-9965.Epi-16-0567  0.434
2017 Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States. Jama Oncology. PMID 28152150 DOI: 10.1001/Jamaoncol.2016.6380  0.399
2017 Hasan Y, Waller J, Yao K, Chmura SJ, Huo D. Utilization trend and regimens of hypofractionated whole breast radiation therapy in the United States. Breast Cancer Research and Treatment. PMID 28120272 DOI: 10.1007/S10549-017-4120-0  0.374
2017 Olopade OI, Nielsen S, Wang S, Bernhisel R, Brown K, Cox HC, Cummings S, Rosenthal ET, Saam J, Lancaster JM, Huo D. Ancestry-based differences in hereditary cancer genetic testing. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13107  0.392
2017 Lee KM, Wang S, Huo D, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Zheng Y, Olopade OI. Association of breast cancer risk in women of African ancestry with genetic variants in the TET-related DNA demethylation pathway. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13015  0.418
2017 Aschebrook-Kilfoy B, Kibriya MG, Chiu BC, Huo D, List MA, Stepniak E, Sarwar G, Shams RA, Gopalakrishnan R, Beau MML, Ahsan H. Variation in screening rates in a multi-ethnic population-based study in Chicago. Journal of Clinical Oncology. 35: 1509-1509. DOI: 10.1200/Jco.2017.35.15_Suppl.1509  0.326
2017 Olopade O, Pitt J, Riester M, Odetunde A, Yoshimatsu T, Labrot E, Ademola A, Sanni A, Okedere B, Mahan S, Nwosu I, Leary R, Ajani M, Johnson R, Sveen E, ... ... Huo D, et al. Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-Pd8-05  0.458
2017 Wang S, Qian F, Zheng Y, Ogundiran T, Ojengbede O, Zheng W, Blot W, Nathanson K, Hennis A, Nemesure B, Ambs S, Olopade O, Huo D. Abstract P5-09-02: Breast cancer risk prediction using a polygenic risk score in women of African ancestry: Findings from GWAS in breast cancer in the African diaspora Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-09-02  0.469
2017 Huo D, Hu H, Rhie S, Gamazon E, Cherniack A, Liu J, Yoshimatsu T, Pitt J, Hoadley K, Troester M, Ru Y, Lichtenberg T, Sturtz L, Shelley C, Mills G, et al. Abstract P1-05-11: Comprehensive comparison of breast cancer molecular portraits by African and European ancestry in the cancer genome atlas Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P1-05-11  0.48
2017 Huo D, Anderson D, Herbst AL. Abstract 709: Incidence and mortality of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: 40 years of long-term follow-up Cancer Research. 77: 709-709. DOI: 10.1158/1538-7445.Am2017-709  0.348
2017 Wang S, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Nathanson KL, Nemesure B, Ambs S, Huo D, Olopade OI. Abstract 1312: Genetic variation in the Hippo pathway and breast cancer risk in women of African ancestry in the ROOT Consortium Epidemiology. 77: 1312-1312. DOI: 10.1158/1538-7445.Am2017-1312  0.44
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, et al. Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer. Human Molecular Genetics. 25: 4835-4846. PMID 28171663 DOI: 10.1093/Hmg/Ddw305  0.492
2016 Han YJ, Zhang J, Zheng Y, Huo D, Olopade OI. Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer. Plos One. 11: e0165559. PMID 27806084 DOI: 10.1371/Journal.Pone.0165559  0.445
2016 Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D. Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine. 95: e4975. PMID 27749552 DOI: 10.1097/Md.0000000000004975  0.462
2016 Huo D, Feng Y, Haddad S, Zheng Y, Yao S, Han YJ, Ogundiran TO, Adebamowo C, Ojengbede O, Falusi AG, Zheng W, Blot W, Cai Q, Signorello L, John EM, et al. Genome-wide Association Studies in Women of African Ancestry Identified 3q26.21 as a Novel Susceptibility Locus for Estrogen Receptor Negative Breast Cancer. Human Molecular Genetics. PMID 27594435 DOI: 10.1093/hmg/ddw305  0.394
2016 Samaeekia R, Adorno-Cruz V, Bockhorn J, Chang YF, Huang S, Prat A, Ha N, Kibria G, Huo D, Zheng H, Dalton R, Wang Y, Moskalenko G, Liu H. MicroRNA-206 inhibits stemness and metastasis of breast cancer by targeting MKL1/IL11 pathway. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27435395 DOI: 10.1158/1078-0432.Ccr-16-0943  0.386
2016 Huo D, Clayton WM, Yoshimatsu TF, Chen J, Olopade OI. Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients. Oncotarget. PMID 27409424 DOI: 10.18632/Oncotarget.10485  0.402
2016 Qian F, Feng Y, Zheng Y, Ogundiran TO, Ojengbede O, Zheng W, Blot W, Ambrosone CB, John EM, Bernstein L, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry. Human Genetics. PMID 27380242 DOI: 10.1007/S00439-016-1707-1  0.402
2016 Liu J, Gustafson P, Huo D. Bayesian adjustment for the misclassification in both dependent and independent variables with application to a breast cancer study. Statistics in Medicine. PMID 27238294 DOI: 10.1002/Sim.6996  0.456
2016 Guindalini RS, Song A, Fackenthal JD, Olopade OI, Huo D. Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect. Cancer. PMID 26992017 DOI: 10.1200/Jco.2014.32.15_Suppl.1550  0.468
2016 Olayiwola O, Ogundiran T, Hardeman A, Yoshimatsu T, Clayton W, Adeoye A, Ademola A, Ajani M, Khramtsova G, Grushko T, Huo D, Zheng Y, Parker J, Perou C, Olopade O. Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-04-05  0.462
2016 Olopade O, Odetunde A, Riester M, Yoshimatsu T, Labrot E, Ademola A, Sanni A, Okedere B, Mahan S, Nwosu I, Leary R, Ajani M, Johnson R, Sveen E, Zheng Y, ... ... Huo D, et al. Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-03-17  0.488
2016 Pitt JJ, Yoshimatsu TF, Zheng Y, Grundstad J, Tuteja J, Wang J, Odetunde A, Khramtsova G, Clayton W, Ademola A, Ogundiran TO, Adeniji-Sofoluwe AT, Obajimi M, Adeoye A, Babalola C, ... ... Huo D, et al. Abstract 4494: Whole genome sequencing reveals different patterns of mutational mechanisms in breast tumors between women of African and European descent Cancer Research. 76: 4494-4494. DOI: 10.1158/1538-7445.Am2016-4494  0.446
2016 Wang S, Ogundiran T, Ademola A, Olayiwola OA, Adeoye A, Adeniji-Sofoluwe A, Morhason-Bello I, Odedina S, Agwai I, Adebamowo C, Obajimi M, Ojengbede O, Olopade OI, Huo D. Abstract 2590: Development and validation of a breast cancer risk prediction model for black women: findings from the Nigerian breast cancer study: Table 1 Epidemiology. 76: 2590-2590. DOI: 10.1158/1538-7445.Am2016-2590  0.478
2016 Machini K, Ndom P, Huo D. Factors affecting the quality of life for women diagnosed with breast in Cameroon Annals of Global Health. 82: 538. DOI: 10.1016/J.Aogh.2016.04.453  0.352
2015 Churpek JE, Marquez R, Neistadt B, Claussen K, Lee MK, Churpek MM, Huo D, Weiner H, Bannerjee M, Godley LA, Le Beau MM, Pritchard CC, Walsh T, King MC, Olopade OI, et al. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. PMID 26641009 DOI: 10.1002/Cncr.29615  0.45
2015 Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, ... ... Huo D, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985  0.424
2015 Huo D, Hou N, Jaskowiak N, Winchester DJ, Winchester DP, Yao K. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Annals of Surgical Oncology. PMID 25820998 DOI: 10.1245/S10434-015-4528-X  0.403
2015 Sighoko D, Ogundiran T, Ademola A, Adebamowo C, Chen L, Odedina S, Anetor I, Ndom P, Gakwaya A, Ojengbede O, Huo D, Olopade OI. Breast cancer risk after full-term pregnancies among African women from Nigeria, Cameroon, and Uganda. Cancer. PMID 25781581 DOI: 10.1002/Cncr.29305  0.376
2015 Ricks PM, Hershow RC, Rahimian A, Huo D, Johnson W, Prachand N, Jimenez A, Wiebel W, Paul W. A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 19: 326-32. PMID 25686142 DOI: 10.5588/Ijtld.14.0471  0.727
2015 Xu J, Chen Y, Huo D, Khramtsov A, Khramtsova G, Zhang C, Goss KH, Olopade OI. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Molecular Carcinogenesis. PMID 25663530 DOI: 10.1002/Mc.22292  0.408
2015 Grimm WA, Messer JS, Murphy SF, Nero T, Lodolce JP, Weber CR, Logsdon MF, Bartulis S, Sylvester BE, Springer A, Dougherty U, Niewold TB, Kupfer SS, Ellis N, Huo D, et al. The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon. Gut. PMID 25645662 DOI: 10.1136/Gutjnl-2014-308735  0.372
2015 Baretta Z, Olopade OI, Huo D. Heterogeneity in hormone-receptor status and survival outcomes among women with synchronous and metachronous bilateral breast cancers. Breast (Edinburgh, Scotland). 24: 131-6. PMID 25534718 DOI: 10.1016/J.Breast.2014.12.001  0.377
2015 Churpek JE, Walsh T, Zheng Y, Moton Z, Thornton AM, Lee MK, Casadei S, Watts A, Neistadt B, Churpek MM, Huo D, Zvosec C, Liu F, Niu Q, Marquez R, et al. Inherited predisposition to breast cancer among African American women. Breast Cancer Research and Treatment. 149: 31-9. PMID 25428789 DOI: 10.1007/S10549-014-3195-0  0.488
2015 O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Huo D, Fleming GF, Ingle JN, Mayer IA, Morrow PKH, Storniolo AM, Forero-Torres A, Poznak CHV, Merkel DE, Rosner GL, Olopade OI, et al. Clinical evaluation of germline polymorphisms (SNPs) associated with capecitabine (C) toxicity (tox) in metastatic breast cancer (MBC). Journal of Clinical Oncology. 33: 1049-1049. DOI: 10.1200/Jco.2015.33.15_Suppl.1049  0.316
2015 Huo D, Hasan Y, Yao K. Abstract P1-15-16: The utilization of hypofractionated breast radiotherapy in the United States between 2003 and 2011 Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P1-15-16  0.444
2015 Huo D, Clayton WM, Yoshimatsu TF, Chen J, Olopade OI. Abstract 3995: Breast cancer molecular subtypes are reflected in circulating microRNA profiles Cancer Research. 75: 3995-3995. DOI: 10.1158/1538-7445.Am2015-3995  0.415
2014 Hou N, Ndom P, Jombwe J, Ogundiran T, Ademola A, Morhason-Bello I, Ojengbede O, Gakwaya A, Huo D. An epidemiologic investigation of physical activity and breast cancer risk in Africa. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2748-56. PMID 25242052 DOI: 10.1158/1055-9965.Epi-14-0675  0.439
2014 Qian F, Ogundiran T, Hou N, Ndom P, Gakwaya A, Jombwe J, Morhason-Bello I, Adebamowo C, Ademola A, Ojengbede O, Olopade OI, Huo D. Alcohol consumption and breast cancer risk among women in three sub-Saharan African countries. Plos One. 9: e106908. PMID 25198723 DOI: 10.1371/Journal.Pone.0106908  0.412
2014 Feng Y, Stram DO, Rhie SK, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Huo D, et al. A comprehensive examination of breast cancer risk loci in African American women. Human Molecular Genetics. 23: 5518-26. PMID 24852375 DOI: 10.1093/Hmg/Ddu252  0.485
2014 Sighoko D, Liu J, Hou N, Gustafson P, Huo D. Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification? The Oncologist. 19: 592-601. PMID 24807915 DOI: 10.1634/Theoncologist.2013-0427  0.411
2014 Yao K, Czechura T, Liederbach E, Winchester DJ, Pesce C, Shaikh A, Winchester DP, Huo D. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003-2011: report from the national cancer database. Annals of Surgical Oncology. 21: 3457-65. PMID 24806115 DOI: 10.1245/S10434-014-3717-3  0.405
2014 Li H, Giger ML, Sun C, Ponsukcharoen U, Huo D, Lan L, Olopade OI, Jamieson AR, Brown JB, Di Rienzo A. Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers. Medical Physics. 41: 031917. PMID 24593735 DOI: 10.1118/1.4865811  0.369
2014 Zheng Y, Huo D, Ogundiran TO, Falusi AG, Ojengbede O, Adebamowo C, Blot WJ, Zheng W, Cai Q, Signorello LB, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, Hennis AJM, et al. Abstract B11: Replication of previously identified breast cancer susceptibility loci in a breast cancer case-control study on women of African ancestry Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B11  0.478
2014 Feng Y, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante S, Bandera EV, Ingles SA, Press MF, ... ... Huo D, et al. Abstract 943: A comprehensive examination of breast cancer risk loci in African American women Cancer Research. 74: 943-943. DOI: 10.1158/1538-7445.Am2014-943  0.488
2013 Walsh T, Zheng Y, Casadei S, Thornton AM, Lee MK, Churpek M, Huo D, Zvosec C, Liu F, Niu Q, Zhang J, Fackenthal J, King MC, Olopade OI. Inherited mutations in breast cancer genes in African American breast cancer patients revealed by targeted genomic capture and next-generation sequencing. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: CRA1501. PMID 28136065 DOI: 10.1200/Jco.2013.31.15_Suppl.Cra1501  0.465
2013 Hou N, Huo D, Dignam JJ. Prevention of colorectal cancer and dietary management. Chinese Clinical Oncology. 2: 13. PMID 25841493 DOI: 10.3978/J.Issn.2304-3865.2013.04.03  0.338
2013 Yao K, Winchester DJ, Czechura T, Huo D. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002. Breast Cancer Research and Treatment. 142: 465-76. PMID 24218052 DOI: 10.1007/S10549-013-2745-1  0.394
2013 Oluwasola AO, Malaka D, Khramtsov AI, Ikpatt OF, Odetunde A, Adeyanju OO, Sveen WE, Falusi AG, Huo D, Olopade OI. Use of Web-based training for quality improvement between a field immunohistochemistry laboratory in Nigeria and its United States-based partner institution. Annals of Diagnostic Pathology. 17: 526-30. PMID 24095629 DOI: 10.1016/J.Anndiagpath.2013.07.003  0.379
2013 Hou N, Hong S, Wang W, Olopade OI, Dignam JJ, Huo D. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. Journal of the National Cancer Institute. 105: 1365-72. PMID 24003037 DOI: 10.1093/Jnci/Djt207  0.491
2013 Czechura T, Winchester DJ, Pesce C, Huo D, Winchester DP, Yao K. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the national cancer data base. Annals of Surgical Oncology. 20: 3223-32. PMID 23975298 DOI: 10.1245/S10434-013-3154-8  0.449
2013 Pesce C, Czechura T, Winchester DJ, Huo D, Winchester DP, Yao K. Axillary surgery among estrogen receptor positive women 70 years of age or older with clinical stage I breast cancer, 2004-2010: a report from the National Cancer Data Base. Annals of Surgical Oncology. 20: 3259-65. PMID 23975297 DOI: 10.1245/S10434-013-3153-9  0.397
2013 Bhatta SS, Hou N, Moton ZN, Polite BN, Fleming GF, Olopade OI, Huo D, Hong S. Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer. Springerplus. 2: 356. PMID 23961419 DOI: 10.1186/2193-1801-2-356  0.454
2013 Hou N, Ogundiran T, Ojengbede O, Morhason-Bello I, Zheng Y, Fackenthal J, Adebamowo C, Anetor I, Akinleye S, Olopade OI, Huo D. Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study. Annals of Epidemiology. 23: 551-7. PMID 23880155 DOI: 10.1016/J.Annepidem.2013.06.008  0.442
2013 Hou N, Huo D. Incidence rate of breast cancer in young women. Jama. 309: 2433. PMID 23780447 DOI: 10.1001/Jama.2013.6456  0.466
2013 Wang PY, Huo D, Sun C, Olopade OI. The use of allelic imbalance to ascertain cis-regulation for human UGT2B7 in vivo. European Journal of Clinical Pharmacology. 69: 1733-5. PMID 23740002 DOI: 10.1007/S00228-013-1538-0  0.321
2013 Davis MB, Liu X, Wang S, Reeves J, Khramtsov A, Huo D, Olopade OI. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity. Molecular Cancer. 12: 40. PMID 23663560 DOI: 10.1186/1476-4598-12-40  0.412
2013 Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Huo D, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212  0.453
2013 Zheng Y, Ogundiran TO, Falusi AG, Nathanson KL, John EM, Hennis AJ, Ambs S, Domchek SM, Rebbeck TR, Simon MS, Nemesure B, Wu SY, Leske MC, Odetunde A, Niu Q, ... ... Huo D, et al. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Carcinogenesis. 34: 1520-8. PMID 23475944 DOI: 10.1093/Carcin/Bgt090  0.477
2013 Hou N, Huo D. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Research and Treatment. 138: 633-41. PMID 23446808 DOI: 10.1007/S10549-013-2434-0  0.468
2013 Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang YF, Huo D, Wen Y, Swanson KE, Qiu T, Lu J, Young Park S, Eileen Dolan M, Perou CM, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11 Nature Communications. 4. PMID 23340433 DOI: 10.1038/Ncomms2393  0.397
2013 Bockhorn J, Yee K, Chang YF, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olopade OI, Clarke MF, Greene GL, Liu H. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion Breast Cancer Research and Treatment. 137: 373-382. PMID 23224145 DOI: 10.1007/S10549-012-2346-4  0.424
2013 Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, Bernstein L, Zheng W, Palmer JR, Hu JJ, Rebbeck TR, Ziegler RG, Nyante S, Bandera EV, Ingles SA, ... ... Huo D, et al. A genome-wide association study of breast cancer in women of African ancestry. Human Genetics. 132: 39-48. PMID 22923054 DOI: 10.1007/S00439-012-1214-Y  0.442
2013 Liu H, Bockhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, Yee K, Chang Y, Huo D, Lu J, Dolan E, Perou CM, Olopade OI, Clarke MF, Greene G. Abstract 832: MicroRNA-30c inhibits human breast tumor chemo-resistance by regulating twinfinlin-1 (TWF1) and IL-11. Cancer Research. 73: 832-832. DOI: 10.1158/1538-7445.Am2013-832  0.38
2013 Bockhorn J, Yee K, Chang Y, Prat A, Huo D, Nwachukwu C, Dalton R, Huang S, Swanson KE, Perou CM, Olufunmilayo OI, Clarke MF, Liu H, Greene G. Abstract 5337: MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion. Cancer Research. 73: 5337-5337. DOI: 10.1158/1538-7445.Am2013-5337  0.426
2013 Yoshimatsu TF, Yao K, Kaul K, Turk MA, Olopade OI, Huo D. Abstract 5332: MicroRNA profile of triple-negative breast cancer and prognosis. Cancer Research. 73: 5332-5332. DOI: 10.1158/1538-7445.Am2013-5332  0.362
2013 Xu J, Chen Y, Khramtsov A, Huo D, Goss K, Olopade OI. Abstract 3132: Beta-catenin regulates c-Myc and CDKN1A expression in breast cancer cells. Cancer Research. 73: 3132-3132. DOI: 10.1158/1538-7445.Am2013-3132  0.378
2013 Han Y, Zhang J, Zheng Y, Huo D, Olopade OI. Abstract 2565: Functional characterization of genetic variants at 16q12 associated with breast cancer in women of African ancestry. Cancer Research. 73: 2565-2565. DOI: 10.1158/1538-7445.Am2013-2565  0.475
2013 Hou N, Huo D. Abstract 143: Breast cancer incidence rate in american women started to increase: Trend analysis from 2000 to 2009. Cancer Research. 73: 143-143. DOI: 10.1158/1538-7445.Am2013-143  0.484
2013 Huo D, Czechura T, Winchester D, Winchester D, Yao K. Abstract P5-14-09: Brachytherapy, 3-dimentional conformal radiotherapy, and intensity modulated radiotherapy for breast cancer patients undergoing breast conservation: Effectiveness and guideline concordance Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P5-14-09  0.444
2013 Yao K, Tomasz C, Pesce C, Huo D, David W, David W, Edward W. Abstract P3-06-14: Increase in the proportion of stage IV breast cancer amongst young women with newly diagnosed breast cancer, report from the National cancer data base, 1998-2009 Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-06-14  0.426
2013 Sighoko D, Hou N, Ogundiran T, Adebamowo C, Ademola A, Ojengbede O, Anetor I, Akinleye S, Ndom P, Gakwaya A, Huo D, Olopade O. Abstract P3-06-13: Transient increase in breast cancer risk after a full term pregnancy among African women Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P3-06-13  0.398
2012 Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women. Plos One. 7: e40494. PMID 22792352 DOI: 10.1371/Journal.Pone.0040494  0.468
2012 Zhang J, Fackenthal JD, Zheng Y, Huo D, Hou N, Niu Q, Zvosec C, Ogundiran TO, Hennis AJ, Leske MC, Nemesure B, Wu SY, Olopade OI. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry. Breast Cancer Research and Treatment. 134: 889-94. PMID 22739995 DOI: 10.1007/S10549-012-2136-Z  0.447
2012 Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, Adebamowo C, Olopade OI. Body fat distribution and breast cancer risk: Findings from the Nigerian breast cancer study Cancer Causes and Control. 23: 565-574. PMID 22367701 DOI: 10.1007/S10552-012-9916-Y  0.452
2012 Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, et al. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Carcinogenesis. 33: 835-40. PMID 22357627 DOI: 10.1093/Carcin/Bgs093  0.424
2012 Ndom P, Um G, Bell EM, Eloundou A, Hossain NM, Huo D. A meta-analysis of male breast cancer in Africa. Breast (Edinburgh, Scotland). 21: 237-41. PMID 22300703 DOI: 10.1016/J.Breast.2012.01.004  0.432
2012 Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Research and Treatment. 136: 355-63. PMID 22245973 DOI: 10.1007/S10549-011-1910-7  0.423
2012 Hou N, Zheng Y, Gamazon ER, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, ... ... Huo D, et al. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 552-6. PMID 22237986 DOI: 10.1158/1055-9965.Epi-11-0979  0.471
2012 Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu SY, Leske MC, Ambs S, Niu Q, Zhang J, ... ... Huo D, et al. Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Research and Treatment. 132: 341-5. PMID 22134622 DOI: 10.1007/S10549-011-1890-7  0.48
2012 Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling RV, Olugbile S, Polite BN, Olopade OI. Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 350-9. PMID 22114137 DOI: 10.1158/1078-0432.Ccr-11-1397  0.376
2012 Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, Nordgard SH, Grushko T, Huo D, Nwachukwu C, Nobel A, Kristensen VN, Børresen-Dale AL, Olopade OI, Perou CM. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Research and Treatment. 133: 865-80. PMID 22048815 DOI: 10.1007/S10549-011-1846-Y  0.387
2012 Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, Niu Q, Huo D, Sveen WE, Ogundiran T, Adebamowo C, Odetunde A, Falusi AG, Olopade OI. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients. International Journal of Cancer. Journal International Du Cancer. 131: 1114-23. PMID 22034289 DOI: 10.1002/Ijc.27326  0.468
2012 Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI. Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer. 118: 1362-70. PMID 21932393 DOI: 10.1002/Cncr.26388  0.461
2012 Sun C, Huo D, Nemesure B, Hennis A, Leske MC, Wu SY, Niu Q, Olopade OI, Di Rienzo A. Lack of association between common UGT2B nonsynonymous single-nucleotide polymorphisms and breast cancer in populations of African ancestry. International Journal of Cancer. Journal International Du Cancer. 130: 2740-2. PMID 21780111 DOI: 10.1002/Ijc.26300  0.334
2012 Sun C, Southard C, Huo D, Hernandez RD, Witonsky DB, Olopade OI, Di Rienzo A. SNP discovery, expression and cis-regulatory variation in the UGT2B genes. The Pharmacogenomics Journal. 12: 287-96. PMID 21358749 DOI: 10.1038/Tpj.2011.2  0.302
2012 Czechura T, Yao K, Huo D, Shaikh A, Winchester DP, Winchester DJ. Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2002-2007: Report from the National Cancer Data Base. Journal of Clinical Oncology. 30: 6040-6040. DOI: 10.1200/Jco.2012.30.15_Suppl.6040  0.396
2012 Hou N, Yao K, Jaskowiak NT, Hasan Y, Winchester DJ, Winchester DP, Huo D. Patterns of regional node irradiation therapy following breast-conserving surgery: Report from the National Cancer Data Base 2003-2007. Journal of Clinical Oncology. 30: 1101-1101. DOI: 10.1200/Jco.2012.30.15_Suppl.1101  0.435
2012 Yao K, Czechura T, Huo D, Winchester DP, Edge SB, Winchester DJ. Utilization of post-lumpectomy radiation therapy in women 70 years of age or older: A report from the National Cancer Data Base. Journal of Clinical Oncology. 30: 1033-1033. DOI: 10.1200/Jco.2012.30.15_Suppl.1033  0.39
2012 Hou N, Gakwaya A, Ndom P, Ojengbede O, Olopade OI, Huo D. Abstract 674: A pilot study of physical activity and breast cancer risk in Africa Cancer Research. 72: 674-674. DOI: 10.1158/1538-7445.Am2012-674  0.42
2012 Huang S, Yee K, Bockhorn J, Kim S, Huo D, Olopade O, Liu H, Greene G. Abstract 4198: Transcriptional regulation of breast cancer microRNAs by GATA3 and TFAP2A Cancer Research. 72: 4198-4198. DOI: 10.1158/1538-7445.Am2012-4198  0.401
2012 Yoshimatsu TF, Zheng Y, Zhang J, Huo D, Olopade OI. Abstract 2620: Contribution of risk variant in miR-125b binding site of BMPR1B in women of African ancestry with breast cancer Cancer Research. 72: 2620-2620. DOI: 10.1158/1538-7445.Am2012-2620  0.451
2012 Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, Simon MS, John EM, Hennis A, Nemesure B, Wu S, Leske MC, Ambs S, Niu Q, Zhang J, ... ... Huo D, et al. Abstract 2606: Absence of association between common genetic polymorphisms in the TERT-CLPTM1L locus and breast cancer risk in women of African descent Cancer Research. 72: 2606-2606. DOI: 10.1158/1538-7445.Am2012-2606  0.451
2012 Khramtsova GF, Islam ABMMK, Khramtsov AI, Lyman P, Chuanhong L, Jene-Sanz A, Sveen WE, Huo D, Lopez-Bigas N, Benevolenskaya EV, Olopade OI. Abstract 1061: EZH2 expression in different subtypes of human breast cancer Cancer Research. 72: 1061-1061. DOI: 10.1158/1538-7445.Am2012-1061  0.428
2012 Miller ME, Kunnavakkam R, Khramtsova G, Khramtsov A, Sylvester B, Huo D, Olopade OI, Goss KH. Abstract B53: Analysis of Wnt signaling as a determinant of racial disparities in colorectal cancer outcomes. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B53  0.373
2012 Yao K, Du H, Tomasz C, Winchester DP, Winchester DJ, Hou N, Huo D. Abstract P4-14-06: Contralateral Prophylactic Mastectomy and Survival: Selection Bias or True Survival Benefit? Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-14-06  0.31
2012 Huo D. Abstract P2-10-21: Prognostic value of estrogen receptor status in women with synchronous or metachronous breast cancers Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-10-21  0.471
2011 Bhatta S, Hou N, Huo D, Polite BN, Fleming GF, Olopade OI, Hong S. Compliance to adjuvant hormone therapy for black and white women with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1555. PMID 28024043 DOI: 10.1200/Jco.2011.29.15_Suppl.1555  0.468
2011 Cappetta A, Nanda R, Liao C, Huo D, Chen LF, Artioli G, Zagonel V, Olopade OI. Adjuvant chemotherapy in American and Italian patients with BRCA1/2-associated breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1084. PMID 28021264 DOI: 10.1200/Jco.2011.29.15_Suppl.1084  0.479
2011 Chen Y, Xu J, Borowicz S, Collins C, Huo D, Olopade OI. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells. Bmc Cancer. 11: 246. PMID 21668996 DOI: 10.1186/1471-2407-11-246  0.35
2011 Sun C, Huo D, Southard C, Nemesure B, Hennis A, Cristina Leske M, Wu SY, Witonsky DB, Olopade OI, Di Rienzo A. A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk. Human Genetics. 130: 767-75. PMID 21660508 DOI: 10.1007/S00439-011-1025-6  0.429
2011 Zheng Y, Zhang J, Niu Q, Olopade OI, Huo D. Germline mutational analysis of the C19orf62 gene in African-American women with breast cancer. Breast Cancer Research and Treatment. 127: 871-7. PMID 21431873 DOI: 10.1007/S10549-011-1445-Y  0.484
2011 Huo D, Melkonian S, Rathouz PJ, Khramtsov A, Olopade OI. Concordance in histological and biological parameters between first and second primary breast cancers. Cancer. 117: 907-15. PMID 20945326 DOI: 10.1002/Cncr.25587  0.477
2011 Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, et al. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Research and Treatment. 128: 703-11. PMID 20842526 DOI: 10.1007/S10549-010-1154-Y  0.453
2011 Huo D, Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, Rebbeck TR, John EM, Hennis A, Nemesure B, Wu S, Ambs S, Niu Q, Zhang J, Cox NJ, et al. Abstract LB-425: Replication of 18 susceptibility loci of breast cancer in women of African ancestry Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-425  0.423
2011 Zheng Y, Huo D, Zhang J, Yoshimatsu TF, Niu Q, Olopade OI. Abstract 5604: Microsatellites in the estrogen (ESR1, ESR2) and androgen receptor (AR) genes and risk of breast cancer in women of African ancestry Cancer Research. 71: 5604-5604. DOI: 10.1158/1538-7445.Am2011-5604  0.488
2011 Khramtsova GF, Ward J, Khramtsov AI, Hope K, Sveen L, Wu S, Brewster K, Huo D, Nemesure B, Hennis AJM, Olopade OI. Abstract 5066: Molecular profiles of breast cancer in Barbados Cancer Research. 71: 5066-5066. DOI: 10.1158/1538-7445.Am2011-5066  0.457
2011 Hou N, Ogundiran TO, Adebamowo CA, Olopade OI, Huo D. Abstract 3734: Alcohol consumption and breast cancer risk among Nigerian women Cancer Research. 71: 3734-3734. DOI: 10.1158/1538-7445.Am2011-3734  0.436
2011 Hou N, Yao K, Winchester DJ, Jaskowiak N, Winchester DP, Huo D. Abstract A62: Secular trends and disparity of adjuvant hormone therapy use for ductal carcinoma in situ: National Cancer Database, 1998–2007 Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-A62  0.444
2010 Ogundiran TO, Huo D, Adenipekun A, Campbell O, Oyesegun R, Akang E, Adebamowo C, Olopade OI. Case-control study of body size and breast cancer risk in Nigerian women American Journal of Epidemiology. 172: 682-690. PMID 20716701 DOI: 10.1093/Aje/Kwq180  0.491
2010 Zheng Y, Zhang J, Hope K, Niu Q, Huo D, Olopade OI. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Research and Treatment. 124: 857-61. PMID 20697805 DOI: 10.1007/S10549-010-1095-5  0.442
2010 Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, Jonasdottir A, Besenbacher S, Kostic JP, Fackenthal JD, Huo D, Adebamowo C, Ogundiran T, Olson JE, Fredericksen ZS, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. Plos Genetics. 6: e1001029. PMID 20661439 DOI: 10.1371/Journal.Pgen.1001029  0.399
2010 Zhang J, Fackenthal JD, Huo D, Zheng Y, Olopade OI. Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population. Breast Cancer Research and Treatment. 124: 573-7. PMID 20596889 DOI: 10.1007/S10549-010-1006-9  0.43
2010 Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. The American Journal of Pathology. 176: 2911-20. PMID 20395444 DOI: 10.2353/Ajpath.2010.091125  0.427
2010 Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflammatory Bowel Diseases. 16: 1352-6. PMID 20027656 DOI: 10.1002/Ibd.21184  0.343
2010 Adeniji KA, Huo D, Khramtsov A, Zhang C, Olopade OI. Molecular profiles of breast cancer in Ilorin, Nigeria. Journal of Clinical Oncology. 28: 1602-1602. DOI: 10.1200/Jco.2010.28.15_Suppl.1602  0.439
2010 Grushko TA, Nwachukwu C, Charoenthammaraksa S, Huo D, Khramtsov A, Mashek H, Zhang C, Xu J, Perou CM, Olopade OI. Evaluation of BRCA1 inactivation by promoter methylation as a marker of triple-negative and basal-like breast cancers. Journal of Clinical Oncology. 28: 10510-10510. DOI: 10.1200/Jco.2010.28.15_Suppl.10510  0.415
2010 Nwachukwu C, Zhang C, Duan S, Huo D, Minn A, Perou C, Olopade O. Abstract 3004: Specific microRNAs associate with aggressive breast tumor phenotypes in an ethnically diverse patient cohort Cancer Research. 70: 3004-3004. DOI: 10.1158/1538-7445.Am10-3004  0.353
2010 Sylvester BE, Huo D, Khramtsov A, Zhang J, Smalling R, Polite B, Olopade OI. Abstract 28: Molecular analysis of colorectal cancer progression in an ethnically diverse cohort reveals a higher prevalence of KRAS mutations in African Americans Cancer Research. 70: 28-28. DOI: 10.1158/1538-7445.Am10-28  0.342
2010 Lubin GP, Khramtsov A, Khramtsova G, Sveen WE, Perou CM, Huo D, Olopade OI. Abstract 1176: αB-Crystallin expression across different stages and subtypes of breast cancer analyzed using tissue microarrays Cancer Research. 70: 1176-1176. DOI: 10.1158/1538-7445.Am10-1176  0.466
2010 Adeyanju O, Khramtsov A, Verma A, Liu L, Wang X, Sattar H, Olopade O, Huo D. Abstract P6-01-06: Identification of Molecular Subtypes of DCIS and Invasive Breast Cancer Using Computerized Image Analysis for Data Integration Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P6-01-06  0.424
2010 Sun C, Huo D, Nemesure B, Hennis A, Witonsky D, Niu Q, Rienzo AD, Olopade O. Abstract P3-12-07: Polymorphisms in the UDP-Glucuronosyltransferase 2B Gene Family and Risk of Breast Cancer in Women of African Descent Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-12-07  0.428
2010 Huo D, Hou N, Ogundiran T, Olopade O. Abstract P3-11-10: Risk Factors for Pregnancy-Associated Breast Cancer: A Report from the Nigerian Breast Cancer Study Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-11-10  0.484
2009 Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, Zhang B, Grushko T, Zhang C, Oluwasola O, Malaka D, Malami S, Odetunde A, Adeoye AO, Iyare F, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4515-21. PMID 19704069 DOI: 10.1200/Jco.2008.19.6873  0.453
2009 Huo D, Hetzel JT, Roy H, Rubin DT. Association of colorectal cancer and prostate cancer and impact of radiation therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1979-85. PMID 19531678 DOI: 10.1158/1055-9965.Epi-09-0241  0.355
2009 Huo D, Senie RT, Daly M, Buys SS, Cummings S, Ogutha J, Hope K, Olopade OI. Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1184-90. PMID 19188678 DOI: 10.1200/Jco.2008.17.5869  0.308
2009 Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry. Familial Cancer. 8: 15-22. PMID 18679828 DOI: 10.1007/S10689-008-9205-9  0.41
2009 Cerri E, Spyrka S, Huo D, Khramtsov A, Khramtsova G, Olopade O, Innocenti F, Nanda R. The role of VEGFR-2 genetic variation in breast cancer progression. Cancer Research. 69: 904. DOI: 10.1158/0008-5472.Sabcs-904  0.368
2009 Malaka D, Khramtsov A, Oluwasola O, Odetunde A, Falusi A, Grushko T, Huo D, Olopade O. Validation of breast cancer biomarkers between a field immunohistochemistry laboratory in Nigeria and its US-based counterpart. Cancer Research. 69: 4039. DOI: 10.1158/0008-5472.Sabcs-4039  0.447
2009 Huo D, Melkonian S, Rathouz P, Khramtsov A, Olopade O. Concordance in Hormone Receptor Status between First and Second Breast Cancers. Cancer Research. 69: 4144-4144. DOI: 10.1158/0008-5472.Sabcs-09-4144  0.492
2009 Rajagopal P, Fackenthal J, Huo D, Niu Q, Zhang J, Kirchhoff T, Offit K, Olopade O. Genetic Risks for Breast Cancer in African American Women: Analysis of Candidate Single Nucleotide Polymorphisms from Association Studies. Cancer Research. 69: 3068-3068. DOI: 10.1158/0008-5472.Sabcs-09-3068  0.482
2009 Tonlaar N, Campbell M, Garwood E, Khramtsov A, Moore D, Au A, Baehner F, Huo D, David M, Oluwasola O, Odetunde A, Tretiakova M, Li S, Gong C, Tonner E, et al. Association of Proliferating Macrophages with High Grade, Hormone Receptor Negative Breast Cancer. Cancer Research. 69: 3042-3042. DOI: 10.1158/0008-5472.Sabcs-09-3042  0.424
2009 Khramtsova G, Liao C, Khramtsov A, Li S, Gong C, Huo D, Nanda R. The M2/Alternatively Activated Macrophage Phenotype Correlates with Aggressive Histopathologic Features and Poor Clinical Outcome in Early Stage Breast Cancer. Cancer Research. 69: 107-107. DOI: 10.1158/0008-5472.Sabcs-09-107  0.391
2008 Olopade OI, Grushko TA, Nanda R, Huo D. Advances in breast cancer: pathways to personalized medicine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7988-99. PMID 19088015 DOI: 10.1158/1078-0432.Ccr-08-1211  0.498
2008 Calderwood AH, Huo D, Rubin DT. Association between colorectal cancer and urologic cancers. Archives of Internal Medicine. 168: 1003-9. PMID 18474765 DOI: 10.1001/Archinte.168.9.1003  0.392
2008 Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H, Olopade OI. Parity and breastfeeding are protective against breast cancer in Nigerian women. British Journal of Cancer. 98: 992-6. PMID 18301401 DOI: 10.1038/Sj.Bjc.6604275  0.489
2008 Garner CP, Ding YC, John EM, Ingles SA, Olopade OI, Huo D, Adebamowo C, Ogundiran T, Neuhausen SL. Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent. Human Genetics. 123: 247-55. PMID 18210156 DOI: 10.1007/S00439-008-0468-X  0.486
2008 Lauderdale DS, Huo D. Cancer death rates for older Asian-Americans: classification by race versus ethnicity. Cancer Causes & Control : Ccc. 19: 135-46. PMID 17992577 DOI: 10.1007/S10552-007-9079-4  0.361
2008 Huo D, Kim HJ, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Niu Q, Sveen L, Fackenthal JD, Fackenthal DL, Das S, Cox N, Di Rienzo A, Olopade OI. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans. Breast Cancer Research and Treatment. 110: 367-76. PMID 17909964 DOI: 10.1007/S10549-007-9720-7  0.459
2008 Ogundiran TO, Huo D, Adebamowo CA, Adenipekun AA, Campbell OB, Olopade OI. Case-control study of height, weight and BMI and breast cancer risk in Nigerian women Journal of Clinical Oncology. 26: 1506-1506. DOI: 10.1200/Jco.2008.26.15_Suppl.1506  0.434
2008 Huo D, Olopade OI. Abstract 3839: Is recent decline in breast cancer incidence equal across different US racial groups? Epidemiology. DOI: 10.1158/1538-7445.Am2008-3839  0.444
2008 Nourani S, Huo D, Strum W, Rubin DT. W1229 5-ASA Therapy and a Lower Inflammatory Score in Chronic Ulcerative Colitis Are Associated with a Decreased Risk of Dysplasia and Colorectal Cancer Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)63080-2  0.319
2007 Huo D, Olopade OI. Genetic testing in diverse populations: are researchers doing enough to get out the correct message? Jama. 298: 2910-1. PMID 18159061 DOI: 10.1001/Jama.298.24.2910  0.442
2007 Matthews AK, Sellergren SA, Huo D, List M, Fleming G. Complementary and Alternative Medicine Use Among Breast Cancer Survivors Journal of Alternative and Complementary Medicine. 13: 555-562. PMID 17604560 DOI: 10.1089/Acm.2007.03-9040  0.46
2007 Nanda R, Huo D, Cook M, Chen L, Hope K, Cummings S, Olopade OI. Outcomes after breast cancer in an ethnically diverse cohort of high-risk patients: Differences in survival based on BRCA1/BRCA2 mutation status Journal of Clinical Oncology. 25: 21116-21116. DOI: 10.1200/Jco.2007.25.18_Suppl.21116  0.484
2007 Collins C, Huo D, Xu J, Bleibel WK, Dolan ME, Olopade OI, Nanda R. Relationship between BRCA1 promoter methylation and sensitivity of breast cancer cell lines to cisplatin and paclitaxel Journal of Clinical Oncology. 25: 21083-21083. DOI: 10.1200/Jco.2007.25.18_Suppl.21083  0.395
2007 Huo D, Senie RT, Terry MB, Daly MB, Buys SS, Olopade OI. BRCA1 and BRCA2 mutation carrier predictions using the BRCAPRO model in clinic-based minority families enrolled in the Breast Cancer Family Registry (B-CFR) Journal of Clinical Oncology. 25: 21037-21037. DOI: 10.1200/Jco.2007.25.18_Suppl.21037  0.314
2006 Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB. Aminosalicylate Therapy in the Prevention of Dysplasia and Colorectal Cancer in Ulcerative Colitis Clinical Gastroenterology and Hepatology. 4: 1346-1350. PMID 17059900 DOI: 10.1016/J.Cgh.2006.08.014  0.313
2006 Jin JO, Lehmann J, Taxy J, Huo D, Stöckle M, Vogelzang NJ, Steinberg G, Stadler WM. Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer. Clinical Genitourinary Cancer. 5: 150-154. PMID 17026804 DOI: 10.3816/Cgc.2006.N.032  0.345
2006 Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma Cancer Research. 66: 2264-2270. PMID 16489030 DOI: 10.1158/0008-5472.Can-05-3676  0.325
2006 Stenson KM, Huo D, Blair E, Cohen EEW, Argiris A, Haraf DJ, Vokes EE. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope. 116: 33-36. PMID 16481805 DOI: 10.1097/01.Mlg.0000185846.27617.Fe  0.308
2005 Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 17: 170-84. PMID 15899754 DOI: 10.1521/Aeap.17.3.170.62900  0.563
2005 Hong AL, Kim HJ, Niu Q, Cummings SA, Huo D, Olopade OI. 5 Association Of Ugt1A1 Polymorphism And Bilirubin Levels In Female Multi-Racial/Ethnic Cohort Journal of Investigative Medicine. 53. DOI: 10.2310/6650.2005.00206.4  0.343
2005 Rubin DT, Gandhi R, Yadron N, Wood G, Huo D. Improving Knowledge of Familial Colorectal Cancer Risk Using the ACG Brochure: 1085 The American Journal of Gastroenterology. 100. DOI: 10.14309/00000434-200509001-01085  0.326
2004 Li LS, Huo D, Karrison T, Larson RA, Olopade O. Is Family History of Breast Cancer Associated with Therapy-Related Myelodysplastic Syndrome and Therapy-Related Leukemia? . Blood. 104: 2018-2018. DOI: 10.1182/Blood.V104.11.2018.2018  0.445
2003 Stadler WM, Huo D, George C, Yang X, Ryan CW, Karrison T, Zimmerman TM, Vogelzang NJ. Prognostic Factors for Survival With Gemcitabine Plus 5-fluorouracil Based Regimens for Metastatic Renal Cancer The Journal of Urology. 170: 1141-1145. PMID 14501711 DOI: 10.1097/01.Ju.0000086829.74971.4A  0.333
2003 Rubin DT, Djordjevic A, Huo D, Yadron N, Hanauer SB. Use of 5-ASA is associated with decreased risk of dysplasia and colon cancer (CRC) in ulcerative colitis (UC) Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80178-6  0.343
2003 Rubin DT, Huo D, Calderwood AH. Risk for colorectal cancer after a urologic malignancy The American Journal of Gastroenterology. 98. DOI: 10.1016/S0002-9270(03)01137-7  0.358
Low-probability matches (unlikely to be authored by this person)
2008 Lotan T, Hickson J, Souris J, Huo D, Taylor J, Li T, Otto K, Yamada SD, Macleod K, Rinker-Schaeffer CW. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Research. 68: 2166-75. PMID 18381422 DOI: 10.1158/0008-5472.Can-07-1568  0.297
2023 Howard FM, Dolezal J, Kochanny S, Khramtsova G, Vickery J, Srisuwananukorn A, Woodard A, Chen N, Nanda R, Perou CM, Olopade OI, Huo D, Pearson AT. Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence. Npj Breast Cancer. 9: 25. PMID 37059742 DOI: 10.1038/s41523-023-00530-5  0.296
2021 Zhao F, Henderson TO, Cipriano TM, Copley BL, Liu M, Burra R, Birch SH, Olopade OI, Huo D. The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort. Cancer. PMID 34292583 DOI: 10.1002/cncr.33798  0.295
2007 Hong AL, Huo D, Kim HJ, Niu Q, Fackenthal DL, Cummings SA, John EM, West DW, Whittemore AS, Das S, Olopade OI. UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 35: 1254-61. PMID 17478602 DOI: 10.1124/Dmd.106.014183  0.295
2023 Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, ... ... Huo D, et al. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. 15: 7. PMID 36703164 DOI: 10.1186/s13073-022-01152-5  0.292
2023 Adedokun B, Ademola A, Makumbi T, Odedina S, Agwai I, Ndom P, Gakwaya A, Ogundiran T, Ojengbede O, Huo D, Olopade OI. Unawareness of breast cancer family history among African women. The Pan African Medical Journal. 45: 188. PMID 38020349 DOI: 10.11604/pamj.2023.45.188.21616  0.291
2005 Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT. 821: Early Association Between Duration of Androgen Deprivation, Life-Style Factors and Bone Mineral Density in Patients with Prostate Cancer: An Analysis During the First 12 Months of Therapy The Journal of Urology. 173: 222-222. DOI: 10.1016/S0022-5347(18)34990-5  0.291
2023 Terman E, Sheade J, Zhao F, Howard FM, Jaskowiak N, Tseng J, Chen N, Hahn O, Fleming G, Huo D, Nanda R. The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer. Breast Cancer Research and Treatment. PMID 37120458 DOI: 10.1007/s10549-023-06943-x  0.289
2023 Terman E, Sheade J, Zhao F, Howard F, Jaskowiak N, Tseng J, Chen N, Hahn O, Fleming G, Huo D, Nanda R. The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer. Research Square. PMID 36993723 DOI: 10.21203/rs.3.rs-2667554/v1  0.289
2021 Saulsberry L, Liao C, Huo D. Hypofractionated Radiotherapy for Breast Cancer: Financial Risk and Expenditures in the U.S. 2008-2017: Expenditure of Hypofractionated Radiotherapy. International Journal of Radiation Oncology, Biology, Physics. PMID 34637883 DOI: 10.1016/j.ijrobp.2021.10.005  0.289
2008 Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K. MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood. 112: 741-9. PMID 18426989 DOI: 10.1182/Blood-2007-11-126508  0.289
2009 Larson S, Campbell N, Huo D, Artz A, Zhang Y, Gajria D, Green M, Rahimova G, Weiner H, Torres M, Odenike O, Godley LA, Rich ES, Thirman M, Larson RA, et al. High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML). Blood. 114: 1048-1048. DOI: 10.1182/Blood.V114.22.1048.1048  0.289
2010 Xu J, Huo D, Chen Y, Nwachukwu C, Collins C, Rowell J, Slamon DJ, Olopade OI. CpG island methylation affects accessibility of the proximal BRCA1 promoter to transcription factors Breast Cancer Research and Treatment. 120: 593-601. PMID 19466541 DOI: 10.1007/S10549-009-0422-1  0.285
2003 Huo D, Lauderdale DS, Li L. Influence of reproductive factors on hip fracture risk in Chinese women Osteoporosis International. 14: 694-700. PMID 12879222 DOI: 10.1007/S00198-003-1429-9  0.285
2024 Freeman JQ, Sheade JB, Zhao F, Olopade OI, Huo D, Nanda R. Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer. Research Square. PMID 38352451 DOI: 10.21203/rs.3.rs-3909360/v1  0.285
2007 Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT. Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy. Urology. 70: 122-6. PMID 17656221 DOI: 10.1016/J.Urology.2007.03.026  0.284
2017 Huo D, Anderson D, Palmer JR, Herbst AL. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecologic Oncology. PMID 28689666 DOI: 10.1016/J.Ygyno.2017.06.028  0.283
2015 Drazer MW, Huo D, Eggener SE. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26056181 DOI: 10.1200/Jco.2015.61.6532  0.282
2012 Larson SM, Campbell NP, Huo D, Artz A, Zhang Y, Gajria D, Green M, Weiner H, Daugherty C, Odenike O, Godley LA, Hyjek E, Gurbuxani S, Thirman M, Sipkins D, et al. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leukemia & Lymphoma. 53: 445-50. PMID 21913806 DOI: 10.3109/10428194.2011.621562  0.281
2013 Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, ... ... Huo D, et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature Genetics. 45: 690-6. PMID 23583978 DOI: 10.1038/Ng.2608  0.28
2009 Onel KB, Huo D, Hastings D, Fryer-Biggs J, Crow MK, Onel K. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults Lupus. 18: 61-66. PMID 19074170 DOI: 10.1177/0961203308094558  0.279
2005 Schreiber MD, Mestan KK, Marks J, Lee G, Hecox K, Huo D. 334 Neurodevelopmental Outcome of Premature Infants Treated with Inhaled Nitric Oxide Pediatric Research. 58: 412-412. DOI: 10.1203/00006450-200508000-00363  0.278
2007 Rubin DT, Ulitsky A, Poston J, Day R, Huo D. What is the most effective way to communicate results after endoscopy? Gastrointestinal Endoscopy. 66: 108-12. PMID 17591482 DOI: 10.1016/J.Gie.2006.12.056  0.278
2004 Ryan CW, Huo D, Hanson M, Stadler WM, Vogelzang NJ. Effect of zoledronic acid (ZA) versus placebo on bone mineral density (BMD) in androgen-deprived prostate cancer patients with and without bone metastases (mets). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4760. PMID 28017063 DOI: 10.1200/Jco.2004.22.14_Suppl.4760  0.277
2009 Cohen EE, Baru J, Huo D, Haraf DJ, Crowley M, Witt ME, Blair EA, Weichselbaum RR, Rosen F, Vokes EE, Stenson K. Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy. Head & Neck. 31: 1013-21. PMID 19340870 DOI: 10.1002/Hed.21062  0.277
2021 Shang L, Hattori M, Fleming G, Jaskowiak N, Hedeker D, Olopade OI, Huo D. Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients. Breast Cancer Research : Bcr. 23: 18. PMID 33541403 DOI: 10.1186/s13058-021-01397-9  0.276
2013 Rubin DT, Huo D, Kinnucan JA, Sedrak MS, McCullom NE, Bunnag AP, Raun-Royer EP, Cohen RD, Hanauer SB, Hart J, Turner JR. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 1601-8.e1-4. PMID 23872237 DOI: 10.1016/J.Cgh.2013.06.023  0.274
2005 Cohen EE, Kane MA, List MA, Brockstein BE, Mehrotra B, Huo D, Mauer AM, Pierce C, Dekker A, Vokes EE. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8418-24. PMID 16322304 DOI: 10.1158/1078-0432.Ccr-05-1247  0.274
2015 Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates following the 2012 United States Preventive Services Task Force recommendation discouraging prostate-specific antigen (PSA)-based screening. Journal of Clinical Oncology. 33: 5026-5026. DOI: 10.1200/Jco.2015.33.15_Suppl.5026  0.273
2021 Kang MM, Hasan Y, Waller J, Saulsberry L, Huo D. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database. Clinical Breast Cancer. PMID 34257001 DOI: 10.1016/j.clbc.2021.05.016  0.272
2014 Qian F, Ogundiran TO, Hou N, Morhason-Bello I, Ademola S, Ojengbede O, Olopade O, Huo D. Association of alcohol consumption and breast cancer risk among women in three sub-Saharan African countries Annals of Global Health. 80: 200-201. DOI: 10.1016/J.Aogh.2014.08.084  0.271
2002 Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study. Lung Cancer (Amsterdam, Netherlands). 38: 65-71. PMID 12367795 DOI: 10.1016/S0169-5002(02)00144-7  0.27
2018 Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406  0.27
2007 Ryan CW, Huo D, Bylow K, Demers LM, Stadler WM, Henderson TO, Vogelzang NJ. Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid. Bju International. 100: 70-5. PMID 17552955 DOI: 10.1111/J.1464-410X.2007.06853.X  0.27
2014 Stein AC, Huo D, Rubin DT. Mo1184 Meta-Analysis of Thiopurine Exposure and Risk of Colonic Neoplasia in Inflammatory Bowel Disease Gastroenterology. 146. DOI: 10.1016/S0016-5085(14)62100-4  0.27
2009 Mohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. Journal of Hepatology. 50: 797-804. PMID 19231016 DOI: 10.1016/J.Jhep.2008.11.017  0.27
2003 Kane S, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis The American Journal of Medicine. 114: 39-43. PMID 12543288 DOI: 10.1016/S0002-9343(02)01383-9  0.269
2012 Drazer MW, Prasad SM, Huo D, Schonberg MA, Eggener SE. Impact of U.S. Preventive Services Task Force recommendation on screening for prostate cancer in men age 75 or older. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 216. PMID 27967904 DOI: 10.1200/Jco.2012.30.5_Suppl.216  0.268
2012 Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates. Jama. 307: 1692-4. PMID 22535850 DOI: 10.1001/Jama.2012.534  0.268
2003 Kane S, Huo D, Magnanti K. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis Clinical Gastroenterology and Hepatology. 1: 170-173. PMID 15017487 DOI: 10.1016/S1542-3565(03)70032-9  0.266
2010 Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost JA, Wade JL, Agamah E, Vokes EE, Fleming GF. A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia. Gynecologic Oncology. 117: 37-40. PMID 20117828 DOI: 10.1016/J.Ygyno.2010.01.013  0.266
2005 Luu HH, Zhou L, Haydon RC, Deyrup AT, Montag AG, Huo D, Heck R, Heizmann CW, Peabody TD, Simon MA, He TC. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Letters. 229: 135-48. PMID 16157226 DOI: 10.1016/J.Canlet.2005.02.015  0.263
2007 Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, van Besien K. Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 40: 1027-32. PMID 17846595 DOI: 10.1038/Sj.Bmt.1705852  0.263
2013 Drazer M, Prasad SM, Huo D, Schonberg MA, Szmulewitz RZ, Dale W, Eggener SE. PSA screening rates in older men in the United States based on nine-year estimated remaining life expectancy. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E16006  0.262
2004 Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Myers M, Brandt SJ, Zhang Y, Vesole DH, Larson RA, Stock W. The Histone Deacetylase Inhibitor Depsipeptide Has Differential Activity in Specific Cytogenetic Subsets of Acute Myeloid Leukemia (AML). Blood. 104: 264-264. DOI: 10.1182/Blood.V104.11.264.264  0.261
2009 Huo D, Lauderdale DS. Leading Causes of Death for Older Asian Americans North American Journal of Medicine & Science. 2: 156. DOI: 10.7156/V2I4P156  0.26
2008 Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Brandt SJ, Green M, Xie J, Zhang Y, Vesole DH, Stiff P, Wright J, Larson RA, Stock W. Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7095-101. PMID 18981008 DOI: 10.1158/1078-0432.Ccr-08-1007  0.26
2003 Bailey SL, Huo D, Garfein RS, Ouellet LJ. The use of needle exchange by young injection drug users. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 67-70. PMID 14501796 DOI: 10.1097/00126334-200309010-00010  0.259
2011 Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE. Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1736-43. PMID 21444863 DOI: 10.1200/Jco.2010.31.9004  0.259
2007 Singh ZN, Huo D, Anastasi J, Smith SM, Karrison T, Le Beau MM, Larson RA, Vardiman JW. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. American Journal of Clinical Pathology. 127: 197-205. PMID 17210514 DOI: 10.1309/Nq3Pmv4U8Yv39Jwj  0.256
2003 Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 102: 43-52. PMID 12623843 DOI: 10.1182/Blood-2002-11-3343  0.256
2006 Ryan CW, Huo D, Demers LM, Beer TM, Lacerna LV. Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. The Journal of Urology. 176: 972-8; discussion 97. PMID 16890673 DOI: 10.1016/J.Juro.2006.04.078  0.255
2010 Meinel LA, Buelow T, Huo D, Shimauchi A, Kose U, Buurman J, Newstead G. Robust segmentation of mass-lesions in contrast-enhanced dynamic breast MR images. Journal of Magnetic Resonance Imaging : Jmri. 32: 110-9. PMID 20578017 DOI: 10.1002/Jmri.22206  0.255
2020 Troisi R, Palmer JR, Hatch EE, Strohsnitter WC, Huo D, Hyer M, Fredriksen-Goldsen KI, Hoover R, Titus L. Gender Identity and Sexual Orientation Identity in Women and Men Prenatally Exposed to Diethylstilbestrol. Archives of Sexual Behavior. PMID 31975033 DOI: 10.1007/S10508-020-01637-7  0.254
2023 Tjader NP, Beer AJ, Ramroop J, Tai MC, Ping J, Gandhi T, Dauch C, Neuhausen SL, Ziv E, Sotelo N, Ghanekar S, Meadows O, Paredes M, Gillespie J, Aeilts A, ... ... Huo D, et al. Association of germline variants with somatic variants in breast tumors in a genome-wide study. Medrxiv : the Preprint Server For Health Sciences. PMID 38106140 DOI: 10.1101/2023.12.06.23299442  0.253
2006 Odenike OM, Alkan S, Sher D, Godwin JE, Huo D, Brandt SJ, Xie J, Zhang Y, Vesole DH, Larson RA, Stock W. The Histone Deacetylase Inhibitor (HDI) Depsipeptide Has Differential Activity in Core Binding Factor AML. Blood. 108: 1956-1956. DOI: 10.1182/Blood.V108.11.1956.1956  0.253
2003 Karrison TG, Huo D, Chappell R. A group sequential, response-adaptive design for randomized clinical trials Controlled Clinical Trials. 24: 506-522. PMID 14500050 DOI: 10.1016/S0197-2456(03)00092-8  0.252
2018 Huo D, Anderson D, Herbst AL. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. The New England Journal of Medicine. 378: 1746-1748. PMID 29719188 DOI: 10.1056/Nejmc1800097  0.252
2010 Dinwiddie SH, Huo D, Gottlieb O. The course of myalgia and headache after electroconvulsive therapy. The Journal of Ect. 26: 116-20. PMID 19710619 DOI: 10.1097/Yct.0B013E3181B07C0A  0.252
2012 Huo D, Hou N, Jaskowiak NT, Hasan Y, Winchester DJ, Winchester DP, Yao K. Postmastectomy radiotherapy for patients with one to three positive lymph nodes: Utilization and benefit. Journal of Clinical Oncology. 30: 1116-1116. DOI: 10.1200/Jco.2012.30.15_Suppl.1116  0.251
2009 Large MC, Huo D, Eggener SE. Number Of Lymph Nodes Resected At Primary Retroperitoneal Lymph Node Dissection And Cancer-Specific Survival For Non-Seminomatous Germ Cell Tumor Of The Testicle The Journal of Urology. 181: 326-326. DOI: 10.1016/S0022-5347(09)60927-7  0.25
2023 Mapoko BSE, Ndi KC, Tabola L, Mouaye V, Douanla P, Nsangou N, Nkeng G, Vanvolkenburgh C, Dzekem B, Huo D, Ndom P, Olopade O. Feasibility of cancer genetic counselling and screening in Cameroon: perceived benefits and barriers. Ecancermedicalscience. 17: 1588. PMID 37799957 DOI: 10.3332/ecancer.2023.1588  0.25
2007 Lotan TL, Lyon M, Huo D, Taxy JB, Brendler C, Foster BA, Stadler W, Rinker-Schaeffer CW. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia. The Journal of Pathology. 212: 386-94. PMID 17577251 DOI: 10.1002/Path.2194  0.249
2007 Ritch CR, Wan RL, Stephens LB, Taxy JB, Huo D, Gong EM, Zagaja GP, Brendler CB. Dietary Fatty Acids Correlate With Prostate Cancer Biopsy Grade and Volume in Jamaican Men The Journal of Urology. 177: 97-101. PMID 17162011 DOI: 10.1016/J.Juro.2006.08.105  0.248
2018 Wang J, Liu Q, Pierce BL, Huo D, Olopade OI, Ahsan H, Chen LS. A meta-analysis approach with filtering for identifying gene-level gene-environment interactions. Genetic Epidemiology. PMID 29430690 DOI: 10.1002/Gepi.22115  0.248
2005 Rosen D, Novakovic R, Goldenberg FD, Huo D, Baldwin ME, Frank JI, Rosengart AJ, Macdonald RL. Racial differences in demographics, acute complications, and outcomes in patients with subarachnoid hemorrhage: a large patient series. Journal of Neurosurgery. 103: 18-24. PMID 16121968 DOI: 10.3171/Jns.2005.103.1.0018  0.248
2004 Ouellet L, Huo D, Bailey SL. HIV risk practices among needle exchange users and nonusers in Chicago Journal of Acquired Immune Deficiency Syndromes. 37: 1187-1196. PMID 15319680 DOI: 10.1097/01.Qai.0000120802.43677.Ea  0.247
2019 Yang F, Cheng J, Huo D. Instrumental variable approach for estimating a causal hazard ratio: application to the effect of postmastectomy radiotherapy on breast cancer patients. Observational Studies. 5: 141-162. PMID 34223564 DOI: 10.1353/obs.2019.0008  0.245
2005 Kline JP, Swamy R, Huo D, Michaelis L, Larson RA, Rich E, Stock W, Ulaszek J, Wickrema A, Artz A, Albitar M, Besien Kv. Alemtuzumab (Campath 1-H) Exposure Correlates with Risk of Chronic Graft vs Host Disease and CMV Viremia after Allogeneic Transplantation. Blood. 106: 1818-1818. DOI: 10.1182/Blood.V106.11.1818.1818  0.245
2004 Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases Cancer Chemotherapy and Pharmacology. 54: 553-561. PMID 15349753 DOI: 10.1007/S00280-004-0857-3  0.244
2006 Konda V, Huo D, Hermes G, Liu M, Patel R, Rubin DT. Do patients with inflammatory bowel disease want genetic testing? Inflammatory Bowel Diseases. 12: 497-502. PMID 16775494 DOI: 10.1097/00054725-200606000-00009  0.244
2011 Burnet DL, Plaut AJ, Wolf SA, Huo D, Solomon MC, Dekayie G, Quinn MT, Lipton R, Chin MH. Reach-out: a family-based diabetes prevention program for African American youth. Journal of the National Medical Association. 103: 269-77. PMID 21671531 DOI: 10.1016/S0027-9684(15)30290-X  0.243
2006 Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, Van Besien K. New Cytogenetic Abnormalities Are Frequent in AML and MDS Relapsing after Allogeneic Hematopoietic Cell Transplantation (HCT). Blood. 108: 3675-3675. DOI: 10.1182/Blood.V108.11.3675.3675  0.242
2021 Strohsnitter WC, Hyer M, Bertrand KA, Cheville AL, Palmer JR, Hatch EE, Aagaard KM, Titus L, Romero IL, Huo D, Hoover RN, Troisi R. Prenatal Diethylstilbestrol Exposure and Cancer Risk in Males. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34272263 DOI: 10.1158/1055-9965.EPI-21-0234  0.241
2008 Rosen DS, Ferguson SD, Ogden AT, Huo D, Fessler RG. Obesity and self-reported outcome after minimally invasive lumbar spinal fusion surgery. Neurosurgery. 63: 956-60; discussion 9. PMID 19005386 DOI: 10.1227/01.Neu.0000313626.23194.3F  0.241
2009 Meinel LA, Bergtholdt M, Abe H, Huo D, Buelow T, Carlsen I, Newstead G. Multi-modality computer-aided diagnosis system for axillary lymph node (ALN) staging: segmentation of ALN on ultrasound images Proceedings of Spie. 7260. DOI: 10.1117/12.811212  0.241
2006 Michaelis LC, Sher D, Myers M, Siddiqui M, Collins-Jones D, Ulaszek J, Huo D, Wickrema A, Besien KV, Stock W. Prognostic significance of WT-1 levels in patients with myelodysplastic syndrome and leukemia after reduced-intensity allogeneic transplantation Journal of Clinical Oncology. 24: 6524-6524. DOI: 10.1200/Jco.2006.24.18_Suppl.6524  0.24
2015 Yao K, Liederbach E, Lutfi W, Wang CH, Hou N, Karrison T, Huo D. Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes. Journal of Surgical Oncology. PMID 26486998 DOI: 10.1002/Jso.24071  0.238
2003 Macdonald RL, Rosengart A, Huo D, Karrison T. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery. 99: 644-52. PMID 14567598 DOI: 10.3171/Jns.2003.99.4.0644  0.238
2007 Huo D, Ouellet LJ. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 108-14. PMID 17460474 DOI: 10.1097/Qai.0B013E318050D260  0.236
2004 Baldwin ME, Macdonald RL, Huo D, Novakovic RL, Novakovia RL, Goldenberg FD, Frank JI, Rosengart AJ. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke; a Journal of Cerebral Circulation. 35: 2506-11. PMID 15472099 DOI: 10.1161/01.Str.0000144654.79393.Cf  0.235
2022 Odedina SO, Ajayi IO, Morhason-Bello IO, Adedokun B, Huo D, Olopade OI, Ojengbede OA. Factors associated with breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, South-western Nigeria. Journal of Public Health in Africa. 13: 1812. PMID 36313925 DOI: 10.4081/jphia.2022.1812  0.235
2006 Odenike OM, Godwin JE, Besien Kv, Huo D, Stiff PJ, Sher D, Klekowski N, Green M, Larson RA, Stock W. Phase II Study of Decitabine in Myelofibrosis with Myeloid Metaplasia. Blood. 108: 4923-4923. DOI: 10.1182/Blood.V108.11.4923.4923  0.235
2009 Patrianakos-Hoobler AI, Msall ME, Marks JD, Huo D, Schreiber MD. Risk factors affecting school readiness in premature infants with respiratory distress syndrome. Pediatrics. 124: 258-67. PMID 19564308 DOI: 10.1542/Peds.2008-1771  0.234
2005 Huo D, Bailey SL, Garfein RS, Ouellet LJ. Changes in the sharing of drug injection equipment among street-recruited injection drug users in Chicago, Illinois, 1994--1996. Substance Use & Misuse. 40: 63-76. PMID 15702649 DOI: 10.1081/Ja-200030495  0.233
2007 Rosen DS, Macdonald RL, Huo D, Goldenberg FD, Novakovic RL, Frank JI, Rosengart AJ. Intraventricular hemorrhage from ruptured aneurysm: clinical characteristics, complications, and outcomes in a large, prospective, multicenter study population. Journal of Neurosurgery. 107: 261-5. PMID 17695378 DOI: 10.3171/Jns-07/08/0261  0.231
2019 Smieliauskas F, Sharma H, Catenacci DVT, Huo D. Population health impact of genome-driven oncology by race and ethnicity. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E18229  0.231
2013 Oluwole O, Arinola OG, Falade GA, Ige MO, Falusi GA, Aderemi T, Huo D, Olopade IO, Olopade CO. Allergy sensitization and asthma among 13-14 year old school children in Nigeria. African Health Sciences. 13: 144-153. PMID 23658581 DOI: 10.4314/Ahs.V13I1.20  0.231
2019 Titus L, Hatch EE, Palmer JR, Huo D, Strohsnitter WC, Adam E, Ricker W, Hyer M, Hoover RN, Troisi R. Prenatal Diethylstilbestrol Exposure and Risk of Depression in Women and Men. Epidemiology (Cambridge, Mass.). PMID 31259848 DOI: 10.1097/Ede.0000000000001048  0.231
2004 Baron BW, Anastasi J, Montag A, Huo D, Baron RM, Karrison T, Thirman MJ, Subudhi SK, Chin RK, Felsher DW, Fu YX, McKeithan TW, Baron JM. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proceedings of the National Academy of Sciences of the United States of America. 101: 14198-203. PMID 15375218 DOI: 10.1073/Pnas.0406138101  0.23
2002 Yamada SD, Hickson JA, Hrobowski Y, Vander Griend DJ, Benson D, Montag A, Karrison T, Huo D, Rutgers J, Adams S, Rinker-Schaeffer CW. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma Cancer Research. 62: 6717-6723. PMID 12438272  0.228
2007 Gomberg-Maitland M, Huo D, Benza RL, McLaughlin VV, Tapson VF, Barst RJ. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 26: 732-8. PMID 17613405 DOI: 10.1016/J.Healun.2007.04.013  0.227
2018 Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, et al. Guidelines for Reporting of Statistics for Clinical Research in Urology. European Urology. PMID 30580902 DOI: 10.1016/J.Eururo.2018.12.014  0.226
2013 Oluwole O, Arinola GO, Ana GR, Wiskel T, Huo D, Olopade OI, Olopade CO. Relationship between household air pollution from biomass smoke exposure, and pulmonary dysfunction, oxidant-antioxidant imbalance and systemic inflammation in rural women and children in Nigeria. Global Journal of Health Science. 5: 28-38. PMID 23777718 DOI: 10.5539/Gjhs.V5N4P28  0.226
2010 Patrianakos-Hoobler AI, Msall ME, Huo D, Marks JD, Plesha-Troyke S, Schreiber MD. Predicting school readiness from neurodevelopmental assessments at age 2 years after respiratory distress syndrome in infants born preterm. Developmental Medicine and Child Neurology. 52: 379-85. PMID 20002128 DOI: 10.1111/J.1469-8749.2009.03343.X  0.226
2011 Ige OM, Arinola OG, Oluwole O, Falade AG, Falusi AG, Aderemi T, Huo D, Olopade OI, Olopade CO. Atopy is associated with asthma in adults living in rural and urban southwestern Nigeria. Journal of Asthma. 48: 894-900. PMID 21861770 DOI: 10.3109/02770903.2011.608458  0.226
2013 Oluwole O, Ana GR, Arinola GO, Wiskel T, Falusi AG, Huo D, Olopade OI, Olopade CO. Effect of stove intervention on household air pollution and the respiratory health of women and children in rural Nigeria Air Quality, Atmosphere & Health. 6: 553-561. DOI: 10.1007/S11869-013-0196-9  0.226
2009 Huo D, Ouellet LJ. Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois. Sexually Transmitted Diseases. 36: 35-40. PMID 19008775 DOI: 10.1097/Olq.0B013E318186Dee3  0.224
2020 Vickers AJ, Assel MJ, Sjoberg DD, Qin R, Zhao Z, Koyama T, Botchway A, Wang X, Huo D, Kattan M, Zabor EC, Harrell F. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. Bju International. PMID 32542947 DOI: 10.1111/Bju.15102  0.224
2020 Vickers AJ, Assel MJ, Sjoberg DD, Qin R, Zhao Z, Koyama T, Botchway A, Wang X, Huo D, Kattan M, Zabor EC, Harrell F. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. The Journal of Urology. 101097JU000000000000. PMID 32441187 DOI: 10.1097/Ju.0000000000001096  0.224
2020 Vickers AJ, Assel MJ, Sjoberg DD, Qin R, Zhao Z, Koyama T, Botchway A, Wang X, Huo D, Kattan M, Zabor EC, Harrell F. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. European Urology. PMID 32451178 DOI: 10.1016/J.Eururo.2020.04.048  0.223
2007 Tennant TR, Huo D, Davis EM, Larson RA, Beau MML. Genomic Rearrangements Associated with -5/del(5q) and -7/del(7q) in Myeloid Leukemias. Blood. 110: 1813-1813. DOI: 10.1182/Blood.V110.11.1813.1813  0.223
2009 Rubin DT, Surma BL, Gavzy SJ, Schnell KM, Bunnag AP, Huo D, Appelbaum DE. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflammatory Bowel Diseases. 15: 750-5. PMID 19090558 DOI: 10.1002/Ibd.20819  0.223
2005 Ferschl MB, Tung A, Sweitzer B, Huo D, Glick DB. Preoperative clinic visits reduce operating room cancellations and delays. Anesthesiology. 103: 855-859. PMID 16192779 DOI: 10.1097/00000542-200510000-00025  0.223
2008 Nimeiri HS, Oza AM, Morgan RJ, Huo D, Elit L, Knost J, Wade Iii JL, Agamah E, Vokes EE, Fleming GF. Sorafenib (SOR) in patients (pts) with advanced/recurrent uterine carcinoma (UCA) or carcinosarcoma (CS): A phase II trial of the University of Chicago, PMH, and California Phase II Consortia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5585. PMID 27950395 DOI: 10.1200/Jco.2008.26.15_Suppl.5585  0.223
2020 Troisi R, Hyer M, Titus L, Palmer JR, Hatch EE, Huo D, Aagaard KM, Strohsnitter WC, Hoover RN. Prenatal diethylstilbestrol exposure and risk of diabetes, gallbladder disease, and pancreatic disorders and malignancies. Journal of Developmental Origins of Health and Disease. 1-8. PMID 33112220 DOI: 10.1017/S2040174420000872  0.221
2016 Cleveland NK, Huo D, Sadiq F, Sofia A, Marks J, Rubin D. Su1866 Long-Term Follow-Up of Polypoid Dysplasia and Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients With IBD-Colitis Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)31965-5  0.221
2023 Omoleye OJ, Woodard AE, Howard FM, Zhao F, Yoshimatsu TF, Zheng Y, Pearson AT, Levental M, Aribisala BS, Kulkarni K, Karczmar GS, Olopade OI, Abe H, Huo D. External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population. Radiology. Artificial Intelligence. 5: e220299. PMID 38074785 DOI: 10.1148/ryai.220299  0.221
2007 Baron BW, Zeleznik-Le N, Baron MJ, Theisler C, Huo D, Krasowski MD, Thirman MJ, Baron RM, Baron JM. Repression of the PDCD2 gene by BCL6 and the implications for the pathogenesis of human B and T cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 104: 7449-54. PMID 17468402 DOI: 10.1073/Pnas.0701770104  0.22
2023 Adejumo PO, Aniagwu TIG, Awolude OA, Adedokun B, Kochheiser M, Sowunmi A, Popoola A, Ojengbede O, Huo D, Olopade OI. Cancer Genetic Services in a Low- to Middle-Income Country: Cross-Sectional Survey Assessing Willingness to Undergo and Pay for Germline Genetic Testing. Jco Global Oncology. 9: e2100140. PMID 36854077 DOI: 10.1200/GO.21.00140  0.219
2012 Hou N, Huo D, Olopade OI. Protective effect of longstanding lactation and reproductive factors: a case-control study in North Tanzania. Breast Cancer Research and Treatment. 134: 1349-51. PMID 21390498 DOI: 10.1007/S10549-011-1391-8  0.219
2006 Gomberg-Maitland M, Huo D, Tapson VF, McLaughlin VV, Benza RL, Barst RJ. 60 Comparison Of Metabolic Equivalent With The 6-Minute Walk Test As A Measure Of Exercise Capacity And Outcome Predictor In Pulmonary Arterial Hypertension: Results From The Intravenous Treprostinil Study. Journal of Investigative Medicine. 54. DOI: 10.2310/6650.2005.X0015.59  0.218
2009 Ouyang KJ, Woo LL, Zhu J, Huo D, Matunis MJ, Ellis NA. SUMO modification regulates BLM and RAD51 interaction at damaged replication forks. Plos Biology. 7: e1000252. PMID 19956565 DOI: 10.1371/Journal.Pbio.1000252  0.218
2018 Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, et al. Guidelines for reporting of statistics for clinical research in urology. Bju International. PMID 30537407 DOI: 10.1111/Bju.14640  0.218
2004 Schreiber K, Cannon RE, Karrison T, Beck-Engeser G, Huo D, Tennant RW, Jensen H, Kast WM, Krausz T, Meredith SC, Chen L, Schreiber H. Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene. 23: 3972-9. PMID 15077191 DOI: 10.1038/Sj.Onc.1207507  0.217
2005 Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. The New England Journal of Medicine. 353: 23-32. PMID 16000353 DOI: 10.1056/Nejmoa043514  0.216
2006 Speer EM, Gentile DA, Zeevi A, Pillage G, Huo D, Skoner DP. Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery. Human Immunology. 67: 915-23. PMID 17145371 DOI: 10.1016/J.Humimm.2006.08.291  0.216
2018 Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, et al. Guidelines for reporting of statistics for clinical research in urology. The Journal of Urology. PMID 30633111 DOI: 10.1097/Ju.0000000000000001  0.216
2002 Karrison T, Archer KJ, Espinosa R, Wen M, Huo D. Data management and statistical methods used in the analysis of balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and therapy-related acute leukemia: report from an international workshop. Genes, Chromosomes & Cancer. 33: 346-61. PMID 11921270 DOI: 10.1002/Gcc.10041  0.213
2011 Patrianakos-Hoobler AI, Marks JD, Msall ME, Huo D, Schreiber MD. Safety and efficacy of inhaled nitric oxide treatment for premature infants with respiratory distress syndrome: follow-up evaluation at early school age. Acta Paediatrica (Oslo, Norway : 1992). 100: 524-8. PMID 21054515 DOI: 10.1111/J.1651-2227.2010.02077.X  0.211
2018 Krugliak Cleveland N, Huo D, Sadiq F, Sofia MA, Marks J, Cohen RD, Hanauer SB, Turner J, Hart J, Rubin DT. Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients with Inflammatory Bowel Disease. Gastrointestinal Endoscopy. PMID 29307473 DOI: 10.1016/J.Gie.2017.12.016  0.211
2007 Odenike O, Godwin JE, Besien Kv, Huo D, Stiff PJ, Wade JL, Lester E, Klekowski N, Larson RA, Stock W. Phase II trial of decitabine in myelofibrosis with myeloid metaplasia Journal of Clinical Oncology. 25: 7088-7088. DOI: 10.1200/Jco.2007.25.18_Suppl.7088  0.21
2017 Oluwole O, Arinola GO, Huo D, Olopade CO. Household biomass fuel use, asthma symptoms severity, and asthma underdiagnosis in rural schoolchildren in Nigeria: a cross-sectional observational study. Bmc Pulmonary Medicine. 17: 3. PMID 28056916 DOI: 10.1186/S12890-016-0352-8  0.21
2003 Sugeng L, Weinert L, Lammertin G, Thomas P, Spencer KT, DeCara JM, Mor-Avi V, Huo D, Feldman T, Lang RM. Accuracy of Mitral Valve Area Measurements Using Transthoracic Rapid Freehand 3-dimensional Scanning: Comparison with Noninvasive and Invasive Methods Journal of the American Society of Echocardiography. 16: 1292-1300. PMID 14652609 DOI: 10.1067/J.Echo.2003.07.005  0.21
2005 Poduval RD, Kadambi PV, Josephson MA, Cohn RA, Harland RC, Javaid B, Huo D, Manaligod JR, Thistlethwaite JR, Meehan SM. Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 79: 228-35. PMID 15665772 DOI: 10.1097/01.Tp.0000148987.13199.10  0.209
2006 Ritch CR, Wan RL, Stephens LB, Taxy JB, Huo D, Zagaja GP, Brendler CB. 486: Increased Erythrocyte Membrane (EM) Linoleic Acid Levels Correlate with Increased Tumor Volume and Gleason Score The Journal of Urology. 175: 158-158. DOI: 10.1016/S0022-5347(18)32742-3  0.207
2003 Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 1980-7. PMID 12743152 DOI: 10.1200/Jco.2003.10.051  0.204
2006 Huo D, Bailey SL, Ouellet LJ. Cessation of injection drug use and change in injection frequency: the Chicago Needle Exchange Evaluation Study. Addiction (Abingdon, England). 101: 1606-13. PMID 17034440 DOI: 10.1111/J.1360-0443.2006.01577.X  0.202
2016 Wei D, Li NL, Zeng Y, Liu B, Kumthip K, Wang TT, Huo D, Ingels JF, Lu L, Shang J, Li K. The Molecular Chaperone GRP78 Contributes to TLR3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes. The Journal of Biological Chemistry. PMID 27129228 DOI: 10.1074/Jbc.M115.711598  0.201
2008 McGreal N, Huo D, Harry R, Toth M, Tierney M, Kirschner B. Age at Menarche and Longitudinal Growth in Pediatric-Onset Inflammatory Bowel Disease: 1352 The American Journal of Gastroenterology. 103. DOI: 10.14309/00000434-200809001-01352  0.199
2007 Kirschner BS, Huo D. Timing Infliximab Therapy in Pediatric Crohn's Disease Gastroenterology. 132: 1167-1170. PMID 17383435 DOI: 10.1053/J.Gastro.2007.01.063  0.199
2024 Freeman JQ, Omoleye OJ, Zhao F, Huo D. Palliative Care Use Trends, Racial/Ethnic Disparities, and Overall Survival Differences Among Patients With Metastatic Breast Cancer. Journal of Palliative Medicine. PMID 38301120 DOI: 10.1089/jpm.2023.0547  0.198
2003 Chi KD, Bekker SV, Park CW, Lee O, Yoshida H, Huo D, Dachman AH, Rubin DT. Virtual dissection (VD) as a novel view of virtual colonoscopy (VC): A feasibility study Gastroenterology. 124. DOI: 10.1016/S0016-5085(03)80561-9  0.197
2008 Rubin D, Surma B, Schnell K, Gavzy S, Bunnag A, Huo D, Appelbaum D. PET/CT Identifies Subclinical Inflammation in Patients with Quiescent Ulcerative Colitis: 1137 The American Journal of Gastroenterology. 103. DOI: 10.14309/00000434-200809001-01137  0.196
2016 Oluwole O, Arinola GO, Huo D, Olopade CO. Biomass fuel exposure and asthma symptoms among rural school children in Nigeria. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 0. PMID 27589676 DOI: 10.1080/02770903.2016.1227334  0.193
2014 Sehdev A, Shih YC, Huo D, Vekhter B, Lyttle C, Polite B. The role of statins for primary prevention in non-elderly colorectal cancer patients. Anticancer Research. 34: 5043-50. PMID 25202089  0.191
2003 Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. The New England Journal of Medicine. 349: 2099-107. PMID 14645637 DOI: 10.1056/Nejmoa031154  0.189
2006 Whiteside LK, Vemulapalli R, Huo D, Cohen RD. The University of Chicago IBD Indirect Costs Scale – Validation of a Novel Disease Impact Scale: 1022 The American Journal of Gastroenterology. 101. DOI: 10.14309/00000434-200609001-01022  0.188
2023 Mapoko BSE, Ndi KC, Tabola L, Mouaye V, Douanla P, Nsangou N, Nkeng G, Vanvolkenburgh C, Dzekem B, Huo D, Ndom P, Olopade O. Erratum: Feasibility of cancer genetic counselling and screening in Cameroon: perceived benefits and barriers. Ecancermedicalscience. 17: 1604. PMID 37799949 DOI: 10.3332/ecancer.2023.1604  0.186
2023 Zhao F, Freeman JQ, Jaskowiak N, Fleming GF, Nanda R, Lauderdale DS, Olopade OI, Huo D. Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic Cohort. Research Square. PMID 37609132 DOI: 10.21203/rs.3.rs-3231825/v1  0.186
2007 Olopade CO, Mensah E, Gupta R, Huo D, Picchietti DL, Gratton E, Michalos A. Noninvasive determination of brain tissue oxygenation during sleep in obstructive sleep apnea: a near-infrared spectroscopic approach. Sleep. 30: 1747-55. PMID 18246984 DOI: 10.1093/Sleep/30.12.1747  0.182
2006 Vemulapalli R, Whiteside LK, Huo D, Cohen RD. IBD Disproportionately Impacts Womensʼ Personal and Professional Lives: 1099 The American Journal of Gastroenterology. 101. DOI: 10.14309/00000434-200609001-01099  0.181
2023 Han Y, Zhu X, Hu Y, Yu C, Guo Y, Hang D, Pang Y, Pei P, Ma H, Sun D, Yang L, Chen Y, Du H, Yu M, Chen J, ... ... Huo D, et al. Electronic Health Record-based Absolute Risk Prediction Model for Esophageal Cancer in the Chinese Population: Model Development and External Validation. Jmir Public Health and Surveillance. PMID 36781293 DOI: 10.2196/43725  0.173
2014 Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ, Eggener SE. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 120: 1491-8. PMID 24523016 DOI: 10.1002/cncr.28600  0.144
2021 Scannell Bryan M, Ogundiran T, Ojengbede O, Zheng W, Blot W, Domcheck S, Hennis A, Nemesure B, Ambs S, Olopade OI, Huo D. Associations between age of menarche and genetic variation in women of African descent: genome-wide association study and polygenic score analysis. Journal of Epidemiology and Community Health. PMID 34706928 DOI: 10.1136/jech-2020-216000  0.141
2021 Howard FM, Dolezal J, Kochanny S, Schulte J, Chen H, Heij L, Huo D, Nanda R, Olopade OI, Kather JN, Cipriani N, Grossman RL, Pearson AT. The impact of site-specific digital histology signatures on deep learning model accuracy and bias. Nature Communications. 12: 4423. PMID 34285218 DOI: 10.1038/s41467-021-24698-1  0.135
2021 Graff M, Justice AE, Young KL, Marouli E, Zhang X, Fine RS, Lim E, Buchanan V, Rand K, Feitosa MF, Wojczynski MK, Yanek LR, Shao Y, Rohde R, Adeyemo AA, ... ... Huo D, et al. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry. American Journal of Human Genetics. PMID 33713608 DOI: 10.1016/j.ajhg.2021.02.011  0.134
2012 Drazer MW, Prasad SM, Huo D, Schonberg MA, Eggener SE. Impact of U.S. Preventive Services Task Force recommendation on screening for prostate cancer in men age 75 or older. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 216. PMID 28142963 DOI: 10.1200/jco.2012.30.5_suppl.216  0.125
2024 Freeman JQ, Huo D. Addressing Social Determinants in the Era of Precision Medicine in Breast Cancer: Is It Sufficient to Reduce Disparities? Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 33: 635-637. PMID 38689576 DOI: 10.1158/1055-9965.EPI-24-0231  0.12
2024 Booth S, Freeman JQ, Li JL, Huo D. Increase in Hypofractionated Radiotherapy among Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ: Who is Left Behind? Practical Radiation Oncology. PMID 38685449 DOI: 10.1016/j.prro.2024.04.010  0.12
2024 McClellan JC, Li JL, Gao G, Huo D. Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status. Breast Cancer Research : Bcr. 26: 51. PMID 38515142 DOI: 10.1186/s13058-024-01809-6  0.12
1998 Wang X, Wei P, Huo D. Non-conditional logistic regression analysis of affecting factors in patients with NIDDM Journal of Xi'An Medical University, Chinese Edition. 19: 461-462+490.  0.105
2003 Deyrup AT, Haydon RC, Huo D, Ishikawa A, Peabody TD, He TC, Montag AG. Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer. 98: 805-13. PMID 12910526 DOI: 10.1002/cncr.11617  0.102
2010 Huo D, Qiu J. The risk evaluation of large-scale sports events based on Bayesian network Proceedings - 2010 Ieee International Conference On Emergency Management and Management Sciences, Icemms 2010. 538-541. DOI: 10.1109/ICEMMS.2010.5563383  0.096
2000 Huo D, Li L. A case - control study on risk factors for hip fracture in the middle - aged and elderly in Beijing Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi. 21: 37-40. PMID 11860756  0.095
2013 Huo D, Mao X. Application of the analytical hierarchy process in a sports events risk assessment Wit Transactions On Engineering Sciences. 80: 745-752.  0.095
2004 Huo Dm, Dong Ft. Recent advances in retinopathy of prematurity Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 26: 83-87. PMID 15052783  0.088
2020 Li S, Odedina S, Agwai I, Ojengbede O, Huo D, Olopade OI. Traditional medicine usage among adult women in Ibadan, Nigeria: a cross-sectional study. Bmc Complementary Medicine and Therapies. 20: 93. PMID 32192455 DOI: 10.1186/s12906-020-02881-z  0.083
2010 Huo D, Olopade OI. Interpretation of genome-wide association study results. Oncology (Williston Park, N.Y.). 24: 643, 646. PMID 20669801  0.073
2020 Vickers AJ, Assel MJ, Sjoberg DD, Qin R, Zhao Z, Koyama T, Botchway A, Wang X, Huo D, Kattan M, Zabor EC, Harrell F. Guidelines for Reporting of Figures and Tables for Clinical Research in Urology. Urology. PMID 32446805 DOI: 10.1016/j.urology.2020.05.002  0.072
2007 Rosen DS, O'Toole JE, Eichholz KM, Hrubes M, Huo D, Sandhu FA, Fessler RG. Minimally invasive lumbar spinal decompression in the elderly: outcomes of 50 patients aged 75 years and older. Neurosurgery. 60: 503-9; discussion 50. PMID 17327795 DOI: 10.1227/01.NEU.0000255332.87909.58  0.064
2006 Jiang Y, Huo D, Wilson DL. Parallel reconstructions of MRI: Evaluation using detection and perceptual difference studies Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6146. DOI: 10.1117/12.655663  0.053
2007 Jiang Y, Huo D, Wilson DL. Methods for quantitative image quality evaluation of MRI parallel reconstructions: detection and perceptual difference model Magnetic Resonance Imaging. 25: 712-721. PMID 17540283 DOI: 10.1016/j.mri.2006.10.019  0.053
2008 Qian S, Huo D, Qian Q. Paraoxonase 1 activity in Northern Chinese diabetic patients with chronic renal failure Acta Endocrinologica. 4: 243-249. DOI: 10.4183/aeb.2008.243  0.052
2007 Li Y, Guo YL, Huo D. Evaluation of autogenous shrinkage of HPC based on AHP-fuzzy method Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 33: 931-936.  0.05
2007 Huo D, Fan S, Zhang Y. Cloning of a phyA gene and its over expression in E. coli Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi. 24: 176-181. PMID 17333917  0.05
2006 Xue X, Huo D, Teng HW. The two stage method of the damage identification of highway bridge based on improved genetic algorithms World Information On Earthquake Engineering. 22: 60-65.  0.048
2012 Song GH, Huo D, Luo L, Wang DW. Influences of prestressing degree on curved box-girder bridges by two-step one-parameter method Beijing Gongye Daxue Xuebao/Journal of Beijing University of Technology. 38.  0.047
2011 Qian S, Huo D, Wang S, Qian Q. Inhibition of glucose-induced vascular endothelial growth factor expression by Salvia miltiorrhiza hydrophilic extract in human microvascular endothelial cells: Evidence for mitochondrial oxidative stress Journal of Ethnopharmacology. 137: 985-991. PMID 21782920 DOI: 10.1016/j.jep.2011.07.018  0.047
2007 Huo D, Cheng K. Modelling and control of two-axis direct drive slides with application to nano/micro machining Proceedings of the 7th International Conference European Society For Precision Engineering and Nanotechnology, Euspen 2007. 2: 81-84.  0.046
2006 Huo D, Wilson DL. Using perceptual difference model to improve GRAPPA reconstruction in MRI Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6146. DOI: 10.1117/12.655607  0.045
2009 Huo D, Cao Q, Xie C, Yang J. A method of improving the performance of continuous data protection system Proceedings of Spie - the International Society For Optical Engineering. 7517. DOI: 10.1117/12.839403  0.045
2008 Miao J, Huo D, Wilson DL. Quantitative image quality evaluation of MR images using perceptual difference models Medical Physics. 35: 2541-2553. PMID 18649487 DOI: 10.1118/1.2903207  0.045
2013 Zhang H, Huo D. Research situation of infant gastrointestinal microbiota Journal of Chinese Institute of Food Science and Technology. 13: 1-6.  0.045
2012 Huo D, Cao Q. Traffic throttling to improve TCP Incast throughput Advanced Materials Research. 424: 227-231. DOI: 10.4028/www.scientific.net/AMR.424-425.227  0.043
2005 Huo D, Wilson DL. Using the Perceptual Difference Model (PDM) to optimize GRAPPA reconstruction Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 7: 7409-7412.  0.042
2010 Huo DY, Yang JQ. Design of distributed computer control system based on the fieldbus for asphalt concrete mixer Iccasm 2010 - 2010 International Conference On Computer Application and System Modeling, Proceedings. 15. DOI: 10.1109/ICCASM.2010.5622496  0.042
2012 Xu H, Yin K, Huo D, Yin G. Research on vehicle optimization scheduling of highway transportation in logistics industry based on GA Applied Mechanics and Materials. 198: 1422-1427. DOI: 10.4028/www.scientific.net/AMM.198-199.1422  0.042
1986 Huo DTC, Hou TW. RETICULATED SINGLE-CRYSTAL LUMINESCENT SCREEN Journal of the Electrochemical Society. 133: 1492-1497.  0.042
2011 Huo D, Cao Q. RTO optimization for TCP incast scenarios International Journal of Advancements in Computing Technology. 3: 119-126. DOI: 10.4156/ijact.vol3.issue8.14  0.042
2005 Yang YH, Zhang QX, Pan XL, Huo D. Realiability analysis of whole stability of soil-nailing wall Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 31: 585-588.  0.042
2005 Gao HD, Huo D, Tao LJ. Lateral displacement prediction of deep excavation combining chaos theory with credible regions Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 31: 136-140.  0.042
2010 Zhang FR, Huo DY. Research of human-simulated intelligent controller in industrial control 2nd International Workshop On Education Technology and Computer Science, Etcs 2010. 3: 216-219. DOI: 10.1109/ETCS.2010.290  0.041
2007 Mohd Nor MK, Huo D, Cheng K. A PC-based control system for multiple-axis micro/nano machining: Control architecture and implementations Laser Metrology and Machine Performance Viii - 8th International Conference and Exhibition On Laser Metrology, Machine Tool, Cmm and Robotic Performance, Lamdamap 2007. 289-298.  0.041
2010 Teng HW, Wang T, Huo D, Su MY. Theoretical analysis and modal test for structural damage diagnosis based on axial vibration Zhendong Yu Chongji/Journal of Vibration and Shock. 29: 122-125.  0.041
2006 Li Y, Huo D, Du XL. Study on the early shrinkage properties of reinforced concrete Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 32: 1002-1006.  0.041
2015 Lin Y, Fang GG, Huo D. Research progress on preparation methods and applications of dextran-based hydrogels Chemistry and Industry of Forest Products. 35: 148-152. DOI: 10.3969/j.issn.0253-2417.2015.06.024  0.04
1996 Lor DT, Nogay D, Huo D, Skip Kingston HM. On-line Chromatographie ICP-MS analysis of traditionally difficult environmental samples Journal of Automatic Chemistry. 18: 96-97.  0.04
2005 Li DJ, Huo D, Han Q. Bridge damage identification via multi measurement with a moving mass Huanan Ligong Daxue Xuebao/Journal of South China University of Technology (Natural Science). 33.  0.04
2014 Wang H, Huo D. Green cloud computing: Site selection of data centers Security, Trust, and Regulatory Aspects of Cloud Computing in Business Environments. 202-214. DOI: 10.4018/978-1-4666-5788-5.ch012  0.04
2000 Huo D, Liu D, Sun P. The morphology design of PBA/P(St-MMA) core/shell latex Acta Polymerica Sinica. 59-60.  0.039
2010 Shi G, Zuo Y, Zheng J, Huo D. Experimental study on the single-layer plane cable net with the influence of damages Jianzhu Jiegou Xuebao/Journal of Building Structures. 31: 9-17.  0.039
2022 Adejumo PO, Oluwasanu MM, Ntekim A, Awolude OA, Kotila OA, Aniagwu T, Brown BJ, Dzekem BS, Duncan S, Tito-Ilori M, Ajani O, Lee SM, Babalola CP, Ojengbede O, Huo D, et al. Oncology Training Needs Assessment Among Health Care Professionals in Nigeria. Jco Global Oncology. 8: e2200017. PMID 35594507 DOI: 10.1200/GO.22.00017  0.039
2006 Huo D, Xu D, Liang ZP, Wilson D. Application of perceptual difference model on regularization techniques of parallel MR imaging. Magnetic Resonance Imaging. 24: 123-32. PMID 16455401 DOI: 10.1016/J.Mri.2005.10.018  0.038
2012 Ren J, Huo D, Li Q. Genetic algorithm for the vehicle scheduling problem of emergency logistics distribution in City World Automation Congress Proceedings 0.038
2006 Huo DH, Cheng K. Design of a piezo-driven fast tool servo (FTS) for diamond cutting: Dynamics and application perspectives Proceedings of the 6th International Conference European Society For Precision Engineering and Nanotechnology, Euspen 2006. 1: 127-130.  0.038
2006 Mohd Hussin Z, Cheng K, Huo D. On-line Modal Identification of a CNC Machining System based on Surface Roughness Laser Scattering: Theoretical Perspectives Intelligent Production Machines and Systems - 2nd I*Proms Virtual International Conference 3-14 July 2006. 191-197. DOI: 10.1016/B978-008045157-2/50038-9  0.038
1980 Huo DJ. Dietary skeletal fluorosis (a roentgen analysis of 34 cases) (author's transl) Zhonghua Fang She Xue Za Zhi Chinese Journal of Radiology. 14: 174-175. PMID 6451401  0.038
2008 Li Y, Guo YL, Huo D. Effect of super mineral powder on autogenous shrinkage of cement paste Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 34: 288-291.  0.038
2005 Li XJ, Huo D, Li DJ, Li WH. Selection of the long-span spatial structural projects based on the unascertained measure Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 31: 272-275.  0.038
2002 Huo D, Liu D. Morphologies of polybutylacrylate/poly(styrene-co-methyl methacrylate) latex prepared by starved emulsion polymerization part I. Thermodynamics equilibrium morphology Polymer International. 51: 585-593. DOI: 10.1002/pi.912  0.037
2006 Li DJ, Huo D. A new approach for modal analysis and damage identification of bridges based on ambient excitation World Information On Earthquake Engineering. 22: 66-69.  0.037
2007 Teng HW, Huo D, Jiang XF, Lin LX. Combination index of damage locating detection for structures Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 33: 493-497.  0.037
2001 Huo D, Zhang J, Sun J, Liu G. Bayesian networks for mapping salinity using the multi-temporal Landsat TM imagery Proceedings of Spie - the International Society For Optical Engineering. 4555: 93-98. DOI: 10.1117/12.441695  0.037
2007 Miao J, Huo D, Wilson D. Perceptual difference model (Case-PDM) for evaluation of MR images: Validation and calibration Progress in Biomedical Optics and Imaging - Proceedings of Spie. 6515. DOI: 10.1117/12.710102  0.037
2014 Huo D. Impact of country-level factors on export competitiveness of agriculture industry from emerging markets Competitiveness Review. 24: 393-413. DOI: 10.1108/CR-01-2012-0002  0.037
2008 Huo D, Wilson DL. Robust GRAPPA reconstruction and its evaluation with the perceptual difference model Journal of Magnetic Resonance Imaging. 27: 1412-1420. PMID 18504764 DOI: 10.1002/jmri.21352  0.036
2009 Jiang Z, Zhang W, Huo D. Stability and bifurcation analysis in a delayed predator-prey system International Journal of Biomathematics. 2: 483-506. DOI: 10.1142/S1793524509000789  0.036
2003 Huo D, Wilson DL, Salem KA, Moriguchi H. Evaluation of Noise Effects in Spiral MRI Image Reconstruction Using the Perceptual Difference Model (PDM) Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 1: 486-489.  0.036
1998 Zhao H, Chen Y, Huo D, Chen H. Analysis of isoenzymes in six kinds of caulis drug by means of polyacrylamide gel slab electrophoresis Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica. 23. PMID 11599380  0.035
2012 Huo D, Feng Y, Song L. Mapping shoreline of Hangzhou Bay with remote sensing images from 1979 to 2005 2012 2nd International Conference On Remote Sensing, Environment and Transportation Engineering, Rsete 2012 - Proceedings. DOI: 10.1109/RSETE.2012.6260621  0.035
2016 Huo D, Pini R, Benson SM. A calibration-free approach for measuring fracture aperture distributions using X-ray computed tomography Geosphere. 12: 558-571. DOI: 10.1130/GES01175.1  0.035
2007 Zhu JF, Huo D, Wang DW. Displacement-based failure dependently analysis of RC non-coupled shear walls under minor earthquakes Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 33: 26-30.  0.034
2010 Huo D, Cheng K. Experimental investigation on micromilling of oxygen-free, high-conductivity copper using tungsten carbide, chemistry vapour deposition, and single-crystal diamond micro tools Proceedings of the Institution of Mechanical Engineers, Part B: Journal of Engineering Manufacture. 224: 995-1003. DOI: 10.1243/09544054JEM1828SC  0.034
2003 Wilson DL, Salem KA, Huo D, Duerk JL. Perception difference paradigm for analyzing image quality of fast mri techniques Proceedings of Spie - the International Society For Optical Engineering. 5034: 297-308. DOI: 10.1117/12.480335  0.034
2012 He JN, Teng HW, Huo D. Analysis of frame structural system reliability using advanced PNET method Beijing Gongye Daxue Xuebao/Journal of Beijing University of Technology. 38: 708-712.  0.033
2016 Huo D, Benson SM. Experimental Investigation of Stress-Dependency of Relative Permeability in Rock Fractures Transport in Porous Media. 1-24. DOI: 10.1007/s11242-016-0713-z  0.033
2012 Huo D, Li S, Fan Q, Li J. The effects of bimodal microstructure characteristics on susceptibility to adiabatic shear bands of modified Ti-6AI-4V alloys Ti 2011 - Proceedings of the 12th World Conference On Titanium. 2: 1074-1078.  0.033
2002 Huo D, Liu D, Sun P. Morphology of poly(butyl acrylate)/poly(styrene-co-methyl methacrylate) latex prepared by starved emulsion polymerization: II. Development of particle morphology Polymer International. 51: 1417-1421. DOI: 10.1002/pi.1072  0.033
2011 Choudhry S, McClinton-Powell L, Solomon M, Davis D, Lipton R, Darukhanavala A, Steenes A, Selvaraj K, Gielissen K, Love L, Salahuddin R, Embil FK, Huo D, Chin MH, Quinn MT, et al. Power-up: a collaborative after-school program to prevent obesity in African American children. Progress in Community Health Partnerships : Research, Education, and Action. 5: 363-73. PMID 22616204  0.033
2013 Huo D, Yang T. Seismic ambient noise around the South China Sea: Seasonal and spatial variations, and implications for its climate and surface circulation Marine Geophysical Research. 34: 449-459. DOI: 10.1007/s11001-013-9176-6  0.033
2011 Song GH, Luo L, Huo D, Wang DW. Influences of different loads on curved box-girder bridges studied with nonlinear function method Beijing Gongye Daxue Xuebao/Journal of Beijing University of Technology. 37: 225-230.  0.032
2012 Huo D, Li Z, Han D. The analysis of temperature rise of dry-type transformer with case China International Conference On Electricity Distribution, Ciced. DOI: 10.1109/CICED.2012.6508447  0.032
2007 Song F, Zhang L, Huo D. Research on technologies of Chongdong double curve arch bridge reinforcement Shenyang Jianzhu Daxue Xuebao (Ziran Kexue Ban)/Journal of Shenyang Jianzhu University (Natural Science). 23: 556-561.  0.032
2006 Teng HW, Jiang JJ, Huo D. Structure damage diagnosis based wavelet transform Wuhan Ligong Daxue Xuebao/Journal of Wuhan University of Technology. 28: 58-60.  0.031
2012 Wang H, Huo D. Server farm site selection using green computing criteria Proceedings - 2012 6th International Conference On New Trends in Information Science, Service Science and Data Mining (Niss, Icmia and Nasnit), Issdm 2012. 63-67.  0.031
2006 Teng HW, Huo D, Li Y. Maintenance strategy optimization of aseismatic structure during design reference period Harbin Gongye Daxue Xuebao/Journal of Harbin Institute of Technology. 38.  0.031
2006 He W, Liu W, Huo D. Shaking table test and numerical analysis for an isolated structure with small aspect ratio under earthquake inputs in two directions Journal of Earthquake Engineering and Engineering Vibration. 26: 218-225.  0.031
2007 Huo D, Liang Y, Cheng K. An investigation of nanoindentation tests on the single crystal copper thin film via an atomic force microscope and molecular dynamics simulation Proceedings of the Institution of Mechanical Engineers, Part C: Journal of Mechanical Engineering Science. 221: 259-266. DOI: 10.1243/0954406JMES448  0.031
2009 Zhang L, Huo D, Zhao Y, Yu J. Research and development of catalyst for diesel fuel hydroupgrading Petroleum Processing and Petrochemicals. 40: 30-32.  0.031
1998 Huo D, Yusheng LU, Kingston HM. Determination and correction of analytical biases and study on chemical mechanisms in the analysis of Cr(VI) in soil samples using EPA protocols Environmental Science and Technology. 32: 3418-3423. DOI: 10.1021/es971029e  0.03
2010 Cheng Y, Huo D. Enlightenment and reference: The study on the practice of subject construction of world famous research-based universities Conference Proceedings - Ieee International Conference On Systems, Man and Cybernetics. 1102-1107. DOI: 10.1109/ICSMC.2010.5642347  0.03
2008 Liu WG, He WF, Huo D. Earthquake response control and dynamic tests research on bridge and building complex structural system Proceedings of the 10th International Symposium On Structural Engineering For Young Experts, Isseye 2008. 1261-1270.  0.03
2007 Liu WG, He WF, Huo D, Fu WQ. Shaking table test and numerical analysis for large aspect ratio isolated structure under bi-directional earthquake input Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 33.  0.03
2003 Li DW, Huo D, Hu CY. Analytic prediction for the steady-state random responses of sliding systems with hardening restoring force Gongcheng Lixue/Engineering Mechanics. 20: 72-75.  0.029
2006 Huo D, Kobayashi T. Sonoresponsive volume phase-transition behavior of crosslinked poly(N-isopropylacrylamide-co-acrylic acid) microgel Chemistry Letters. 35: 776-777. DOI: 10.1246/cl.2006.776  0.029
2010 Huo D. Analysis of influences from exchange rate to pricing of China steel industry 2010 International Conference On System Science and Engineering, Icsse 2010. 115-118. DOI: 10.1109/ICSSE.2010.5551825  0.029
2008 Hou C, Yang L, Huo D. Spectrophotometric detection of dimethyl methyl-phosphonate using plant-esterase 2nd International Conference On Bioinformatics and Biomedical Engineering, Icbbe 2008. 1640-1643. DOI: 10.1109/ICBBE.2008.739  0.029
2012 Huo D. Real-time delay statistics in wireless IP networks Advances in Radio Science. 10: 105-111. DOI: 10.5194/ars-10-105-2012  0.029
2000 Wang Z, Er G, Yuan C, Huo D. Development of CAD platform for an practical AC speed-adjusting system based on device net Proceedings of the World Congress On Intelligent Control and Automation (Wcica). 4: 2409-2411.  0.029
2010 Huo D, Cheng K, Wardle F. Design of a five-axis ultra-precision micro-milling machine-UltraMill. Part 2: Integrated dynamic modelling, design optimisation and analysis International Journal of Advanced Manufacturing Technology. 47: 879-890. DOI: 10.1007/s00170-009-2129-1  0.029
2015 Huo D, Chen Y, Wang H. Analysis of complex network in international business literature Proceedings of the 2015 Ieee 9th International Conference On Semantic Computing, Ieee Icsc 2015. 436-439. DOI: 10.1109/ICOSC.2015.7050846  0.029
2007 Guo ZX, Huo D, Zhang MJ. Fuzzy random reliability analysis of rammed soil-cement pile composite foundation based on load test Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 33: 382-387.  0.028
2010 Huo D, Gong B. Discrete modeling and simulation on potential leakage through fractures in CO2 sequestration Proceedings - Spe Annual Technical Conference and Exhibition. 6: 5132-5147.  0.028
2005 Baron BW, Langan G, Huo D, Baron JM, Montag A. Squamous cell carcinomas of the skin at ear tag sites in aged FVB/N mice. Comparative Medicine. 55: 231-5. PMID 16089170  0.028
2010 Huo D, Cheng K, Wardle F. A holistic integrated dynamic design and modelling approach applied to the development of ultraprecision micro-milling machines International Journal of Machine Tools and Manufacture. 50: 335-343. DOI: 10.1016/j.ijmachtools.2009.10.009  0.028
2009 Huo D, Yang L, Hou C. Optical detection of dimethyl methyl-phosphonate with monosulfonate tetraphenyl porphyrin-plant-esterase complex Sensor Letters. 7: 72-78. DOI: 10.1166/sl.2009.1012  0.028
2010 Huo D, Gong B. Numerical simulation on CO 2 leakage through fractures along wells using discrete fracture modeling Society of Petroleum Engineers - Spe Asia Pacific Oil and Gas Conference and Exhibition 2010, Apogce 2010. 3: 1613-1629.  0.028
2006 Xia MJ, Huo D. System reliability index based structural design for building frames Beijing Gongye Daxue Xuebao / Journal of Beijing University of Technology. 32.  0.028
2008 Huo D, Cheng K. A dynamics-driven approach to the design of precision machine tools for micro-manufacturing and its implementation perspectives Proceedings of the Institution of Mechanical Engineers, Part B: Journal of Engineering Manufacture. 222: 1-13. DOI: 10.1243/09544054JEM839  0.027
Hide low-probability matches.